Home

Publications

  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  1. A. Musinguzi, H. E. Aschmann, J. L. Kadota, J. Nakimuli, F. Welishe, J. Kakeeto, C. Namale, L. Akello, A. Nakitende, C. Berger, A. Katamba, J. Tumuhamye, N. Kiwanuka, D. W. Dowdy, A. Cattamanchi, F. C. Semitala. Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda 
  2. Cecilia Akatukwasa, Brian Beesiga, Asiphas Owaraganise, Joan Nangendo, Elijah Kakande, Florence Mwangwa, Susan Nayiga, Fred C. Semitala, Moses R. Kamya, Jane Kabami. Client and provider experiences with, and approaches to sustain HIV care during the COVID‑19 pandemic restrictions at two public hospitals in southwestern Uganda.
  3. Fred C. Semitala ,Jillian L. Kadota ,Allan Musinguzi,Fred Welishe,Anne Nakitende,Lydia Akello,Lynn Kunihira Tinka,Jane Nakimuli,Joan Ritar Kasidi,Opira Bishop,Suzan Nakasendwa,Yeonsoo Baik,Devika Patel,Amanda Sammann,Payam Nahid,Robert Belknap,Moses R. Kamya,Margaret A. Handley,Patrick PJ Phillips,Anne Katahoire,Christopher A. Berger,Noah Kiwanuka,Achilles Katamba,David W. Dowdy ,Adithya Cattamanchi. Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial
  4. Canice Christian, Elijah Kakande, Violah Nahurira, Cecilia Akatukwasa, Fredrick Atwine, Robert Bakanoma, Harriet Itiakorit, Asiphas Owaraganise, William DiIeso, Derek Rast, Jane Kabami, Jason Johnson Peretz, Starley B. Shade, Moses R. Kamya, Diane V. Havlir, Gabriel Chamie and Carol S. Camlin.Mid-level managers’ perspectives on implementing isoniazid preventive therapy for people living with HIV in Ugandan health districts: a qualitative study
  5. Emmanuel Musisi, PhD. Samuel Wamutu, PhD. Willy Ssengooba, PhD. Sharifah Kasiinga, BBLT. Abdulwahab Sessolo, MSc. Ingvar Sanyu, MPH. Sylvia Kaswabuli, MSc. Josephine Zawedde, MPH. Patrick Byanyima, MSc. Praiscillia Kia, MSc. William Muwambi, BSc. Divine Tracy Toskin, BSc. Edgar Kigozi, MSc. Natasha Walbaum, MSc. Evelin Dombay, PhD. Mate Bonifac Legrady, PhD. Kizza David-Martin Ssemambo, MBChB. Prof Moses Joloba, PhD. Davis Kuchaka, MSc. William Worodria, PhD. Prof Laurence Huang, MD. Prof Stephen H Gillespie, DSc. Wilber Sabiiti, PhD. Accuracy of the tuberculosis molecular bacterial load assay to diagnose and monitor response to anti-tuberculosis therapy: a longitudinal comparative study with standard-of-care smear microscopy, Xpert MTB/RIF Ultra, and culture in Uganda
  6. Gustavo C. Corrêa, Md. Jasim Uddin, Tasnuva Wahed, Moses R. Kamya, Elizabeth Oliveras, Christopher Morgan, Patience Kabatangare, Faith Namugaya, Dorothy Leab, Didier Adjakidje, Patrick Nguku, Adam Attahiru, Jenny Sequeira, Nancy Vollmer and HeidiW.Reynolds. Measuring Zero-Dose Children: Reflections on Age Cohort Flexibilities for Targeted Immunization Surveys at the Local Level
  1. Irene Maeria, Patrick Eyulb, Monica Getahunc, Khalela Hatchettd, Lawrence Owinoa, Cecilia Akatukwasab, Harriet Itiakoritb, Sarah A. Guting, Jason Johnson-Peretzc, Sarah Ssalie, Craig R. Cohenc, Elizabeth A. Bukusia, Moses R. Kamyab,f, Edwin D. Charleboisg, Carol S. Camlin. Community-based participatory research to improve HIV care for mobile patients in Kenya and Uganda
  2. Sarah B. Puryear1,§ , Florence Mwangwa2, Fred Opel3, Gabriel Chamie1 , Laura B. Balzer4, Jane Kabami2, James Ayieko3 , Asiphas Owaraganise2, Elijah Kakande2 , George Agengo3, Elizabeth Bukusi3, Stella Kabageni2, Daniel Omoding2, Melanie Bacon5, John Schrom1, Sarah Woolf-King6, Maya L. Petersen4, Diane V. Havlir1 , Moses Kamya7 and Judith A. Hahn. Puryear HLI SEARCH Phase A JIAS 2023
  3. Elijah R. Kakande1,§ , James Ayieko2 , Helen Sunday1, Edith Biira1, Marilyn Nyabuti2, George Agengo2, Jane Kabami1,3, Colette Aoko2, Hellen N. Atuhaire1, Norton Sang2, Asiphas Owaranganise1, Janice Litunya2, Erick W. Mugoma4, Gabriel Chamie5 , James Peng6, John Schrom5, Melanie C. Bacon7, Moses R. Kamya1,3, Diane V. Havlir5 , Maya L. Petersen8, Laura B. Balzer8 and for the SEARCH Study Team. A community-based dynamic choice model for HIV prevention improves PrEP and PEP coverage in rural Uganda and Kenya: a cluster randomized trial
  4. Kakande, E., Christian, C., Balzer, L. B., Owaraganise, A., Nugent, J. K., DiIeso, W., Rast, D., Kabami, J., Peretz, J. J., Camlin, C. S., Shade, S. B., Geng, E., Kwarisiima, D., Kamya, M. R., Havlir, D. V., & Chamie, G. (2022). A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda: a cluster randomised trial. The Lancet HIV, 9(9), e607–e616. A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda: a cluster randomised trial
  5. Muhindo MK, Bress J, Armas J, Danziger E, Wu A, Brewster RCL. The utilization of clinical decision support tools to identify neonatal hypothermia and its associated risk factors: A prospective observational study. PLOS Glob Public Health. 2023 Feb 9;3(2):e0000982. doi: 10.1371/journal.pgph.0000982. PMID: 36962972; PMCID: PMC10022021
  6. Marquez C, Chen Y, Atukunda M, Chamie G, Balzer LB, Kironde J, Ssemmondo E, Mwangwa F, Kabami J, Owaraganise A, Kakande E, Abbott R, Ssekyanzi B, Koss C, Kamya MR, Charlebois ED, Havlir DV, Petersen ML. The Association Between Social Network Characteristics and Tuberculosis Infection Among Adults in 9 Rural Ugandan Communities. Clin Infect Dis. 2023 02 08; 76(3):e902-e909.  PMID: 35982635.
  7. Christian C, Kabami J, Kwarisiima D, Beinamatsiko B, Nakato H, Khakshi JW, Sulaiman M, Komugisha A, Thirumurthy H, Havlir DV, Kamya MR, Chamie G. Feasibility and preliminary effectiveness of integrating HIV prevention into an adolescent empowerment and livelihood intervention at youth clubs in rural Uganda. AIDS Care. 2023 Jan; 35(1):41-47.  PMID: 36473203; PMCID: PMC10006396.
  8. Okorie CN, Gutin SA, Getahun M, Lebu SA, Okiring J, Neilands TB, Ssali S, Cohen CR, Maeri I, Eyul P, Bukusi EA, Charlebois ED, Camlin CS. Sex specific differences in HIV status disclosure and care engagement among people living with HIV in rural communities in Kenya and Uganda. PLOS Glob Public Health. 2023; 3(4):e0000556.  PMID: 37027350; PMCID: PMC10081749.
  1. Fred C. Semitala, Lelia H. Chaisson, David W. Dowdy, Derek T. Armstrong, Bishop Opira, Kyomugisha Aman, Moses Kamya, Patrick P. J. Phillips & Christina Yoon. Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trial.
  2. Sabapathy K, Balzer L, Larmarange J, Block L, Floyd S, Iwuji C, Wirth K, Ayles H, Fidler S, Kamya M, Petersen M, Havlir D, Dabis F, Moore J, Hayes R. Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan Africa. BMC Public Health. 2022 12 13; 22(1):2333.  PMID: 36514036; PMCID: PMC9746009.
  3.  Hickey MD, Owaraganise A, Sang N, Opel FJ, Mugoma EW, Ayieko J, Kabami J, Chamie G, Kakande E, Petersen ML, Balzer LB, Kamya MR, Havlir DV. Effect of a one-time financial incentive on linkage to chronic hypertension care in Kenya and Uganda: A randomized controlled trial. PLoS One. 2022; 17(11):e0277312.  PMID: 36342940; PMCID: PMC9639834.
  4. Camlin CS, Getahun M, Koss CA, Owino L, Akatukwasa C, Itiakorit H, Onyango A, Bakanoma R, Atwine F, Maeri I, Ayieko J, Atukunda M, Owaraganise A, Mwangwa F, Sang N, Kabami J, Kaplan RL, Chamie G, Petersen ML, Cohen CR, Bukusi EA, Kamya MR, Havlir DV, Charlebois ED. Providers’ Attitudes and Experiences with Pre-Exposure Prophylaxis Implementation in a Population-Based Study in Kenya and Uganda. AIDS Patient Care STDS. 2022 10; 36(10):396-404.  PMID: 36201226; PMCID: PMC9595612.
  5. Pujol-Hodge E, Salazar-Gonzalez JF, Ssemwanga D, Charlebois ED, Ayieko J, Grant HE, Liegler T, Atkins KE, Kaleebu P, Kamya MR, Petersen M, Havlir DV, Leigh Brown AJ. Detection of HIV-1 Transmission Clusters from Dried Blood Spots within a Universal Test-and-Treat Trial in East Africa. Viruses. 2022 07 29; 14(8).  PMID: 36016295; PMCID: PMC9414799.
  6. Kakande E, Christian C, Balzer LB, Owaraganise A, Nugent JR, DiIeso W, Rast D, Kabami J, Johnson Peretz J, Camlin CS, Shade SB, Geng EH, Kwarisiima D, Kamya MR, Havlir DV, Chamie G. A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda: a cluster randomised trial. Lancet HIV. 2022 09; 9(9):e607-e616.  PMID: 35908553; PMCID: PMC9536151.
  7. Johnson-Peretz J, Lebu S, Akatukwasa C, Getahun M, Ruel T, Lee J, Ayieko J, Mwangwa F, Owino L, Onyango A, Maeri I, Atwine F, Charlebois ED, Bukusi EA, Kamya MR, Havlir DV, Camlin CS. “I was still very young”: agency, stigma and HIV care strategies at school, baseline results of a qualitative study among youth in rural Kenya and Uganda. J Int AIDS Soc. 2022 07; 25 Suppl 1:e25919.  PMID: 35818888; PMCID: PMC9274360.
  8. Mwangwa F, Charlebois ED, Ayieko J, Olio W, Black D, Peng J, Kwarisiima D, Kabami J, Balzer LB, Petersen ML, Kapogiannis B, Kamya MR, Havlir DV, Ruel TD. Two or more significant life-events in 6-months are associated with lower rates of HIV treatment and virologic suppression among youth with HIV in Uganda and Kenya. AIDS Care. 2022 May 16; 1-11.  PMID: 35578398; PMCID: PMC9666617.
  9. Phillips AN, Bershteyn A, Revill P, Bansi-Matharu L, Kripke K, Boily MC, Martin-Hughes R, Johnson LF, Mukandavire Z, Jamieson L, Meyer-Rath G, Hallett TB, Ten Brink D, Kelly SL, Nichols BE, Bendavid E, Mudimu E, Taramusi I, Smith J, Dalal S, Baggaley R, Crowley S, Terris-Prestholt F, Godfrey-Faussett P, Mukui I, Jahn A, Case KK, Havlir D, Petersen M, Kamya M, Koss CA, Balzer LB, Apollo T, Chidarikire T, Mellors JW, Parikh UM, Godfrey C, Cambiano V, HIV Modelling Consortium. Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study. Lancet HIV. 2022 05; 9(5):e353-e362.  PMID: 35489378; PMCID: PMC9065367.
  10. Ayieko J, Petersen ML, Kamya MR, Havlir DV. PEP for HIV prevention: are we missing opportunities to reduce new infections? J Int AIDS Soc. 2022 05; 25(5):e25942.  PMID: 35633097; PMCID: PMC9142817.
  11. Jakubowski A, Kabami J, Balzer LB, Ayieko J, Charlebois ED, Owaraganise A, Marquez C, Clark TD, Black D, Shade SB, Chamie G, Cohen CR, Bukusi EA, Kamya MR, Petersen M, Havlir DV, Thirumurthy H. Effect of universal HIV testing and treatment on socioeconomic wellbeing in rural Kenya and Uganda: a cluster-randomised controlled trial. Lancet Glob Health. 2022 01; 10(1):e96-e104.  PMID: 34919862.
  12. Camlin CS, Marson K, Ndyabakira A, Getahun M, Emperador D, Byamukama A, Kwarisiima D, Thirumurthy H, Chamie G. Understanding the role of incentives for achieving and sustaining viral suppression: A qualitative sub-study of a financial incentives trial in Uganda. PLoS One. 2022; 17(6):e0270180.  PMID: 35749510; PMCID: PMC9231797.
  13. Alcover KC, Emenyonu NI, Fatch R, Kekibiina A, Marson K, Chamie G, Muyindike WR, Beesiga B, Kamya MR, Lodi S, Kane JC, Hahn JA, McDonell MG. Concordance Between Point-of-Care Urine Ethyl Glucuronide Alcohol Tests and Self-Reported Alcohol Use in Persons with HIV in Uganda. AIDS Behav. 2022 Aug; 26(8):2539-2547.  PMID: 35103888; PMCID: PMC9256760.
  14. Balzer LB, van der Laan M, Ayieko J, Kamya M, Chamie G, Schwab J, Havlir DV, Petersen ML. Two-Stage TMLE to reduce bias and improve efficiency in cluster randomized trials. Biostatistics. 2021 Dec 23.  PMID: 34939083.
  15. Maeri I, Eyul P, Getahun M, Hatchett K, Owino L, Akatukwasa C, Itiakorit H, Gutin SA, Johnson-Peretz J, Ssali S, Cohen CR, Bukusi EA, Kamya MR, Charlebois ED, Camlin CS. Nothing about us without us: Community-based participatory research to improve HIV care for mobile patients in Kenya and Uganda. Soc Sci Med. 2023 Feb; 318:115471.  PMID: 36628879.
  16. Mucunguzi Atukunda, Jane Kabami, Gerald Mutungi , Brian Twinamatsiko, Joan Nangendo, Starley B Shade, Edwin Charlebois, Heiner Grosskurth, Moses Kamya, Emmy Okello. Rationale and design of leveraging the HIV platform for hypertension control in Africa: protocol of a cluster-randomised controlled trial in Uganda. BMJ Open 2022. 
  17. Kreutzfeld O, Tumwebaze PK, Byaruhanga O, Katairo T, Okitwi M, Orena S, Rasmussen SA, Legac J, Conrad MD, Nsobya SL, Aydemir O, Bailey JA, Duffey M, Cooper RA, Rosenthal PJ. Decreased susceptibility to dihydrofolate reductase inhibitors associated with genetic polymorphisms in Ugandan Plasmodium falciparum isolates. J Infect Dis 2022;225(4):696-704. PMID: 34460932; PMCID: PMC8844592. 
  18. Namuganga JF, Nankabirwa JI, Maiteki-Ssebuguzi C, Gonahasa S, Opigo J, Staedke SG, Rutazaana D, Ebong C, Dorsey G, Tomko SS, Kizza T, Mawejje HD, Arinaitwe E, Rosenthal PJ, Kamya MR,. East Africa International Center of Excellence for Malaria Research: Impact on Malaria Policy in Uganda. Am J Trop Med Hyg 2022;107:33-39. PMID: 36228904; PMCID: PMC9662221.
  19. Rek J, Blanken SL, Okoth J, Ayo D, Onyige I, Musasizi E, Ramjith J, Andolina C, Lanke K, Arinaitwe E, Olwoch P, Collins KA, Kamya MR, Dorsey G, Drakeley C, Staedke SG, Bousema T, Conrad MD,. Asymptomatic School-Aged Children Are Important Drivers of Malaria Transmission in a High Endemicity Setting in Uganda. J Infect Dis 2022;226(4): 708-13. PMID: 35578987 PMCID: PMC9441202.
  20. Okiring J, Epstein A, Namuganga JF, Kamya EV, Nabende I, Nassali M, Sserwanga A, Gonahasa S, Muwema M, Kiwuwa SM, Staedke SG, Kamya MR, Nankabirwa JI, Briggs J, Jagannathan P, Dorsey G. Gender difference in the incidence of malaria diagnosed at public health facilities in Uganda. Malar J 2022;21(1):22. PMID: 35062952; PMCID: PMC8778495.
  21. Briggs J, Takahashi S, Nayebare P, Cuu G, Rek J, Zedi M, Kizza T, Arinaitwe E, Nankabirwa JI, Kamya M, Jagannathan P, Jacobson K, Rosenthal PJ, Dorsey G, Greenhouse B, Ssewanyana I, Rodríguez-Barraquer I. Reconstructing the SARS-CoV-2 epidemic in eastern Uganda through longitudinal serosurveillance in a malaria cohort. medRxiv. 2022. PMID: 36172117; PMCID: PMC9516854.
  22. Nankabirwa JI, Rek J, Arinaitwe E, Namuganga JF, Nsobya SL, Asua V, Mawejje HD, Epstein A, Greenhouse B, Rodriguez-Barraquer I, Briggs J, Krezanoski PJ, Rosenthal PJ, Conrad M, Smith D, Staedke SG, Drakeley C, Bousema T, Andolina C, Donnelly MJ, Kamya MR, Dorsey G. East Africa International Center of Excellence for Malaria Research: Summary of Key Research Findings. Am J Trop Med Hyg 2022; 107(4_Suppl): 21-32. PMID: 36228916; PMCID: PMC9662228.
  23. Musiime A, Krezanoski P, Smith DL, Kilama M, Conrad M, Otto G, Kyagamba P, Asiimwe J, Rek J, Nankabirwa J, Arinaitwe E, Akol A, Kamya MR, Staedke SG, Drakeley C, Bousema T, Lindsay SW, Dorsey G, Tusting LS. House design and risk of malaria, acute respiratory infection and gastrointestinal illness in Uganda: A cohort study. PLOS Global Public Health 2022; doi.org/10.1371/journal.pgph.0000063. PMID: pending; PMCID: pending.
  24. Epstein A, Maiteki-Sebuguzi C, Namuganga JF, Nankabirwa JI, Gonahasa S, Opigo J, Staedke SG, Rutazaana D, Arinaitwe E, Kamya MR, Bhatt S, Rodríguez-Barraquer I, Greenhouse B, Donnelly MJ, Dorsey G. Resurgence of malaria in Uganda despite sustained indoor residual spraying and repeated long lasting insecticidal net distributions. PLOS Global Public Health 2022; doi.org/10.1371/journal.pgph.0000676. PMID: pending; PMCID: pending.
  25. Nankabirwa JI, Arinaitwe E, Briggs J, Rek J, Rosenthal PJ, Kamya MR, Olwoch P, Smith DL, Rodriguez-Barraquer I, Dorsey G, Greenhouse B. Simulating the Impacts of Augmenting Intensive Vector Control with Mass Drug Administration or Test-and-Treat Strategies on the Malaria Infectious Reservoir. Am J Trop Med Hyg 2022;107(5):1028-35. PMID: 36191870; PMCID: PMC9709029.
  26. Okiring J, Gonahasa S, Nassali M, Namuganga JF, Bagala I, Maiteki-Sebuguzi C, Opigo J, Nabende I, Nangendo J, Kabami J, Ssewanyana I, Kiwuwa SM, Nankabirwa JI, Dorsey G, Briggs J, Kamya MR, Staedke SG. LLIN Evaluation in Uganda Project (LLINEUP2)-Factors associated with coverage and use of long‑lasting insecticidal nets following the 2020-21 national mass distribution campaign: a cross-sectional survey of 12 districts. Malar J 2022;21:293. PMID: 36261818; PMCID: PMC9580445. 
  27. Alexander SM, Agaba A, Campbell JI, Nambogo N, Camlin CS, Johnson M, Dorsey G, Olson KR, Bangsberg DR, Carroll RW, Santorino D, Krezanoski PJ. A qualitative study of the acceptability of remote electronic bednet use monitoring in Uganda. BMC Public Health 2022;22(1);1010. PMID: 35590303; PMCID: PMC9118600.
  28. Sadoine ML, Smargiassi A, Liu Y, Gachon P, Dueymes G, Dorsey G, Fournier M, Nankabirwa JI, Rek J, Zinszer K. The influence of the environment and indoor residual spraying on malaria risk in a cohort of children in Uganda. Sci Rep 2022; 12(1):11537. PMID: 35798826; PMCID: PMC9262898. 
  29. Chan JA, Loughland JR, de la Parte L, Okano S, Ssewanyana I, Nalubega M, Nankya F, Musinguzi K, Rek J, Arinaitwe E, Tipping P, Bourke P, Andrew D, Dooley N, SheelaNair A, Wines BD, Hogarth PM, Beeson JG, Greenhouse B, Dorsey G, Kamya M, Hartel G, Minigo G, Feeney M, Jagannathan P, Boyle MJ. Age-dependent changes in circulating Tfh cells influence development of functional malaria antibodies in children. Nat Commun 2022;13(1):4159. PMID: 35851033; PMCID: PMC9293980.
  30. Mawejje HD, Asiimwe JR, Kyagamba P, Kamya MR, Rosenthal PJ, Lines J, Dorsey G, Staedke SG. Impact of different mosquito collection methods on indicators of Anopheles malaria vectors in Uganda. Malar J 2022;21(1):388. PMID: 36536428; PMCID: PMC9761930.
  31. Nankabirwa JI, Bousema T, Blanken SL, Rek J, Arinaitwe E, Greenhouse B, Rosenthal PJ, Moses R Kamya MR, Staedke SG, Dorsey G. Measures of malaria transmission, infection, and disease in an area bordering two districts with and without sustained indoor residual spraying of insecticide in Uganda. PLoS One 2022;17(12):e0279464. PMID: 36584122; PMCID: PMC9803187.
  32. Mawejje HD, Weetman D, Epstein A, Lynd A, Opigo J, Opigo J, Maiteki‑Sebuguzi C, Lines J, Kamya MR, Rosenthal PJ, Donnelly MJ, Dorsey G, Staedke SG. Characterizing pyrethroid resistance and mechanisms in Anopheles gambiae (s.s.) and Anopheles arabiensis from 11 districts in Uganda. Curr Res Parasitol Vector Borne Dis 2022;3:100106. PMID: 36590346; PMCID: PMC9798136. 
  33. Deshmukh SS, Byaruhanga O, Tumwebaze P, Akin D, Greenhouse B, Egan ES, Demirci U. Automated Recognition of Plasmodium falciparum Parasites from Portable Blood Levitation Imaging. Adv Sci (Weinh) 2022;9(28):e2105396. PMID: 35957519; PMCID: PMC9534981.
  34. Gonzales SJ, Clarke KN, Batugedara G, Garza R, Braddom AE, Reyes RA, Ssewanyana I, Garrison KC, Ippolito GC, Greenhouse B, Bol S, Bunnik EM. A Molecular Analysis of Memory B Cell and Antibody Responses Against Plasmodium falciparum Merozoite Surface Protein 1 in Children and Adults From Uganda. Front Immunol 2022;13:809264. PMID: 35720313; PMCID: PMC9201334.
  35. Bachman CM, Cate DM, Grant B, Burkot S, Mulondo J, Hsieh HV, Chamai M, Odongo B, Olwoch P, Nalubega M, Ochokoru H, Kasozi J, Ategeka J, Nichols KP, Weigl BH, Greenhouse B. A Novel Malaria Lateral Flow Assay for Detecting Plasmodium falciparum Lactate Dehydrogenase in Busia, Uganda Am J Trop Med Hyg 2022;106(3):850-852. PMID: 35026727; PMCID: PMC8922488
  36. Ty M, Sun S, Callaway PC, Rek J, Press KD, van der Ploeg K, Nideffer J, Hu Z, Klemm S, Greenleaf W, Donato M, Tukwasibwe S, Arinaitwe E, Nankya F, Musinguzi K, Andrew D, de la Parte L, Mori DM, Lewis SN, Takahashi S, Rodriguez-Barraquer I, Greenhouse B, Blish C, Utz PJ, Khatri P, Dorsey G, Kamya M, Boyle M, Feeney M, Ssewanyana I, Jagannathan P. Malaria-driven expansion of adaptive-like functional CD56-negative NK cells correlates with clinical immunity to malaria. Sci Transl Med 2023;15(680):eadd9012. PMID: 36696483; PMCID: pending.
  37. Briggs J, Takahashi S, Nayebare P, Cuu G, Rek J, Zedi M, Kizza T, Arinaitwe E, Nankabirwa JI, Kamya M, Jagannathan P, Jacobson K, Rosenthal PJ, Dorsey G, Greenhouse B, Ssewanyana I, Rodríguez-Barraquer I. Seroprevalence of Antibodies to SARS-CoV-2 in Rural Households in Eastern Uganda, 2020-2022. JAMA Netw Open 2023;6(2):e2255978. PMID: 36790811; PMCID: PMC9932849.
  38. Ivanochko D, Fabra-García A, Teelen K, van de Vegte-Bolmer M, van Gemert GJ, Newton J, Semesi A, de Bruijni M, Bolscher J, Ramjith J, Szabat M, Vogt S, Kraft L, Duncan S, Lee SM, Kamya MR, Feeney ME, Jagannathan P, Greenhouse B, Sauerwein RW, Richter King C, MacGill RS, Bousema T, Jore MM, Julien JP. Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230. Immunity 2023;56(2):420-432. PMID: 36792575; PMCID: PMC9942874.
  39. Fabra-García A, Hailemariam S, de Jong RM, Janssen K, Teelen K, van de Vegte-Bolmer M, van Gemert GJ, Ivanochko D, Semesi A, McLeod B, Vos MW, de Bruijni MHC, Bolscher JM, Szabat M, Vogt S, Kraft L, Duncan S, Kamya MR, Feeney ME, Jagannathan P, Greenhouse B, Dechering KJ, Sauerwein RW, King CR, MacGill RS, Bousema T, Julien JP, Jore MM. Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes. Immunity 2023;56(2):406-419. PMID: 36792574; PMCID: PMC994287
  40. Hong H, Aslam-Mir U, Kajubi R, Wallender E, Mwebaza N, Dorsey G, Rosenthal PJ, Aweeka FT, Huang L. Antimicrob Agents Chemother. Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention. 2023 Apr 18;67(4):e0142722. doi: 10.1128/aac.01427-22. Epub 2023 Mar 14.
  41. Bangirana P, Conroy AL, Opoka RO, Semrud-Clikeman M, Jang JH, Apayi C, Kakuru A, Muhindo MK, Georgieff MK, Dorsey GM, Kamya MR, Havlir D, John CC.Effect of Malaria and Malaria Chemoprevention Regimens in Pregnancy and Childhood on Neurodevelopmental and Behavioral Outcomes in Children at 12, 24, and 36 Months: A Randomized Clinical Trial. Clin Infect Dis. 2023 Feb 18;76(4):600-608. doi: 10.1093/cid/ciac815.
  42. Hughes E, Wallender E, Kajubi R, Jagannathan P, Ochieng T, Kakuru A, Kamya MR, Clark TD, Rosenthal PJ, Dorsey G, Aweeka F, Savic RM.Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women. Clin Infect Dis. 2022 Aug 31;75(3):406-415. doi: 10.1093/cid/ciab965.
  43. Jasper EA, Oltman SP, Rogers EE, Dagle JM, Murray JC, Kamya M, Kakuru A, Kajubi R, Ochieng T, Adrama H, Okitwi M, Olwoch P, Jagannathan P, Clark TD, Dorsey G, Ruel T, Jelliffe-Pawlowski LL, Ryckman KK.J Perinatol. Targeted newborn metabolomics: prediction of gestational age from cord blood. 2022 Feb;42(2):181-186. doi: 10.1038/s41372-021-01253-w. Epub 2022 Jan 24.PMID: 35067676 Free PMC article.
  44. Zalwango JF, Nankabirwa JI, Kitutu FE, Akunzirwe R, Buhuguru R, Rokani JB, Ssendikwanawa E, Kiguli S, Arinaitwe E, Kalyango JN, 2022. Malaria diagnostic and treatment practices for febrile children under 5 years at two general hospitals in Karamoja, a high transmission setting in Uganda. Malar J 21: 312.
  45. Ochola B, Nankabirwa J, Buwembo W, Kaddumukasa M, Mayanja-Kizza H, 2022. The Clinical Presentation and Factors Associated with Disease Severity of Rheumatoid Arthritis in Uganda: A Cross-Sectional Study. Open Access Rheumatol 14: 75-86.
  46. Nkurunziza JC, Nabukeera-Barungi N, Kalyango JN, Niyongabo A, Mwanja MM, Mupere E, Nankabirwa JI, 2022. Prevalence and factors associated with anaemia in children aged 6-24 months living a high malaria transmission setting in Burundi. PLoS One 17: e0273651.
  47. Muwema M, Kaye DK, Edwards G, Nalwadda G, Nangendo J, Okiring J, Mwanja W, Ekong EN, Kalyango JN, Nankabirwa JI, 2022. Perinatal care in Western Uganda: Prevalence and factors associated with appropriate care among women attending three district hospitals. PLoS One 17: e0267015.
  48. Kamya C, Namugaya F, Opio C, Katamba P, Carnahan E, Katahoire A, Nankabirwa J, Okiring J, Waiswa P, 2022. Coverage and Drivers to Reaching the Last Child With Vaccination in Urban Settings: A Mixed-Methods Study in Kampala, Uganda. Glob Health Sci Pract 10.
  49. Byakika-Kibwika P, Kamya MR, Nankabirwa J, 2022. Ivermectin for mass drug administration against malaria. Lancet Infect Dis 22: 433-435.
  50. Zhang W, Azibani F, Libhaber E, Nankabirwa J, Okello E, Kayima J, Ssinabulya I, Sliwa K, 2022. The role of conventional echocardiographic parameters on detecting subclinical anthracycline therapy related cardiac dysfunction-The SATRACD study. Front Cardiovasc Med 9: 966230.
  51. Zhang H, Ginn J, Zhan W, Leung A, Liu YJ, Toita A, Okamoto R, Wong TT, Imaeda T, Hara R, Michino M, Yukawa T, Chelebieva S, Tumwebaze PK, Vendome J, Beuming T, Sato K, Aso K, Rosenthal PJ, Cooper RA, Liverton N, Foley M, Meinke PT, Nathan CF, Kirkman LA, Lin G.J. Structure-Activity Relationship Studies of Antimalarial Plasmodium Proteasome Inhibitors─Part II. Med Chem. 2023
  52. Okek EJ, Ocan M, Obondo SJ, Kiyimba A, Arinaitwe E, Nankabirwa J, Ssewanyana I, Kamya MR, 2023. Effects of anti-malarial prophylaxes on maternal transfer of Immunoglobulin-G (IgG) and association to immunity against Plasmodium falciparum infections among children in a Ugandan birth cohort. PLoS One 18: e0277789.
  53. Balzer LB, van der Laan M, Ayieko J, Kamya M, Chamie G, Schwab J, Havlir DV, Petersen ML, 2023. Two-Stage TMLE to reduce bias and improve efficiency in cluster randomized trials. Biostatistics 24: 502-517.
  54. Musoke D, Atusingwize E, Namata C, Ndejjo R, Wanyenze RK, Kamya MR, 2023. Integrated malaria prevention in low- and middle-income countries: a systematic review. Malar J 22: 79.
  55. Sessolo A, Musisi E, Kaswabuli S, Zawedde J, Byanyima P, Sabiiti W, Walimbwa S, Ola J, Sanyu I, Lalitha R, Kamya M, Davis L, Worodria W, Huang L, 2023. Diagnostic accuracy of Xpert MTB/RIF Ultra and culture assays to detect Mycobacterium Tuberculosis using OMNIgene-sputum processed stool among adult TB presumptive patients in Uganda. PLoS One 18: e0284041.
  1. Fred C Semitala , Jillian L Kadota , Allan Musinguzi , Juliet Nabunje, Fred Welishe, Anne Nakitende , Lydia Akello , Opira Bishop, Devika Patel, Amanda Sammann, Payam Nahid, Robert Belknap, Moses R Kamya, Margaret A Handley, Patrick P J Phillips, Anne Katahoire, Christopher A Berger, Noah Kiwanuka,Achilles Katamba, David W Dowdy, Adithya Cattamanchi.Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
  2. Fred C. Semitala, Allan Musinguzi, Jackie Ssemata, Fred Welishe, Juliet Nabunje, Jillian L. Kadota, Christopher A. Berger, Achilles Katamba, Noah Kiwanuka, Moses R. Kamya, David Dowdy, Adithya Cattamanchi & Anne R. Katahoire. Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives
  3. Muhindo M, Bress J, Kalanda R, Armas J, Danziger E, Kamya MR, Butler LM, Ruel T. Implementation of a Newborn Clinical Decision Support Software (NoviGuide) in a Rural District Hospital in Eastern Uganda: Feasibility and Acceptability Study. JMIR Mhealth Uhealth. 2021 Feb 19;9(2):e23737. doi: 10.2196/23737. PMID: 33605886; PMCID: PMC7935651. Read more
  4. Impact of seasonality and malaria control interventions on Anopheles density and species composition from three areas of Uganda with differing malaria endemicityMalaria Journal 20(1) DOI: 10.1186/s12936-021-03675-5
    Henry Ddumba Mawejje, Maxwell Kilama, Simon P. Kigozi, Alex K. Musiime, Moses Kamya, Jo Lines, Steven W. Lindsay, David Smith, Grant Dorsey, Martin J. Donnelly & Sarah G. Staedke Read more
  5. Age-related Changes in Malaria Clinical Phenotypes During Infancy are Modified by Sickle Cell TraitClinical Infectious Diseases DOI: 10.1093/cid/ciab245
    Nicholas Zehner, Harriet Adrama, Abel Kakuru, Teddy Andra, Richard Kajubi, Melissa Conrad, Felistas Nankya, Tamara D Clark, Moses Kamya, Isabel Rodriguez-Barraquer, Grant Dorsey, Prasanna Jagannathan Read more
  6. Gestational age dating using newborn metabolic screening: A validation study in Busia, UgandaDOI: 10.7189/jogh.11.04012
    Scott P Oltman1,2, Elizabeth A Jasper3, Richard Kajubi4, Teddy Ochieng4, Abel Kakuru4, Harriet Adrama4, Martin Okitwi4, Peter Olwoch4, MosesKamya4,5, Bruce Bedell6 , Molly McCarthy2, JohnDagle6, Prasanna Jagannathan7, Tamara D Clark8,Grant Dorsey8, Larry Rand2,9, Theodore Ruel10,Elizabeth E Rogers10, Kelli K Ryckman3, Laura L Jelliffe-Pawlowski1,2 Read more
  1. Jillian L. Kadota, Allan Musinguzi, Juliet Nabunje, Fred Welishe, Jackie L. Ssemata, Opira Bishop, Christopher A. Berger, Devika Patel, Amanda Sammann, Anne Katahoire, Payam Nahid, Robert Belknap, Patrick P. J. Phillips, Jennifer Namusobya, Moses Kamya, Margaret A. Handley, Noah Kiwanuka, Achilles Katamba, David Dowdy, Fred C. Semitala & Adithya Cattamanchi. Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda
  2. Efficacy and safety of oxygen-sparing nasal reservoir cannula for treatment of pediatric hypoxemic pneumonia in Uganda: a pilot randomized clinical trial. BMC Pulmonary Medicine, 20(1), 1-12.
    Jerry Mulondo, Stella Maleni, Hellen Aanyu-Tukamuhebwa, Ezekiel Mupere, Alfred Onubia Andama, Chin Hei Ng, Stephen Burkot, Ella M. E. Forgie, Qaasim Mian, Christine M. Bachman, Gerard Rummery, Daniel Lieberman, David Bell5, Michael T. Hawkes and Akos Somoskovi5Read more
  3. “Hunger will kill us before the coronavirus does!”
    Africa is particularly vulnerable to the coronavirus and the effects of these restrictions given the weak healthcare infrastructure, the huge burden of diseases especially malaria, HIV and tuberculosis, high levels of malnutrition and food scarcity, high percentage of the urban population in informal settlements, high levels of poverty and unemployment with many living hand to mouth and a lack of facilities like running water for sanitation and good hygiene.
    Through ongoing ethnographic fieldwork in the Antimicrobials in Society (AMIS) Project, the authors of these notes have come to learn about the everyday realities of the people engaged with as characterized by precarious employment, uncertain economic opportunities, a lack of safety nets, scarcity of quality healthcare, climate instability and being unable to afford the basic needs of life, let alone a full course of antibiotics. The AMIS project is a social science research project aimed at understanding the roles of antimicrobials in society and everyday life. Download Article
  4. New Chemical Combination for Insecticide-Treated Bed Nets Could Prevent More Infections by Overcoming Mosquito Resistance, Major Trial Finds. astmhpressroom.wordpress.com/annual-meeting-2019.For immediate release.
    Read more
  1. Leveraging incentives to increase HIV testing uptake among men: qualitative insights from rural Uganda. BMC Public Health. 2019 Dec 30;19(1):1763. doi: 10.1186/s12889-019-8073-6.
    Ndyabakira A, Getahun M, Byamukama A, Emperador D, Kabageni S, Marson K, Kwarisiima D, Chamie G, Thirumurthy H, Havlir D, Kamya MR, Camlin CS Read more
  2. Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa. AIDS. 2019 Nov 12. doi: 10.1097/QAD.0000000000002427. [Epub ahead of print].
    Puryear SB, Balzer LB, Ayieko J, Kwarisiima D, Hahn JA, Charlebois ED, Clark TD, Cohen CR, Bukusi EA, Kamya MR, Petersen ML, Havlir DV, Chamie G Read more
  3. Systematic review of the status of pfhrp2 and pfhrp3 gene deletion, approaches and methods used for its estimation and reporting in Plasmodium falciparum populations in Africa: review of published studies 2010-2019.Malar J. 2019 Nov 6;18(1):355. doi: 10.1186/s12936-019-2987-4.
    Agaba BB, Yeka A, Nsobya S, Arinaitwe E, Nankabirwa J, Opigo J, Mbaka P, Lim CS, Kalyango JN, Karamagi C, Kamya MR Read more
  4. Machine learning to identify persons at high-risk of HIV acquisition in rural Kenya and Uganda: Clinical Infectious Diseases, ciz1096.07 November 2019
    Laura B Balzer, Diane V Havlir, Moses R Kamya, Gabriel Chamie, Edwin D Charlebois, Tamara D Clark, Catherine A Koss, Dalsone Kwarisiima, James Ayieko, Norton Sang, Jane Kabami, Mucunguzi Atukunda, Vivek Jain, Carol S Camlin, Craig R Cohen, Elizabeth A Bukusi, Mark van der Laan, Maya L Petersen. Read more
  5. Brief Report: Yield and Efficiency of Intensified Tuberculosis Case-Finding Algorithms in 2 High-Risk HIV Subgroups in Uganda. J Acquir Immune Defic Syndr. 2019 Dec 1;82(4):416-420. doi: 10.1097/QAI.0000000000002162.
    Semitala FC, Cattamanchi A, Andama A, Atuhumuza E, Katende J, Mwebe S, Asege L, Nakaye M, Kamya MR, Yoon C Read more
  6. The impact of multiple rounds of indoor residual spraying on malaria incidence and haemoglobin levels in a high transmission setting. J Infect Dis. 2019 Oct 10. pii: jiz453. doi: 10.1093/infdis/jiz453. [Epub ahead of print].
    Zinszer K, Charland K, Vahey S, Jahagirdar D, Rek JC, Arinaitwe E, Nankabirwa J, Morrison K, Sadoine ML, Tutt-Guérette MA, Staedke SG, Kamya MR, Greenhouse B, Rodriguez-Barraquer I, Dorsey G Read more
  7. Reaching 90-90-90 in rural communities in East Africa: lessons from the Sustainable East Africa Research in Community Health Trial.Curr Opin HIV AIDS. 2019 Sep 25. doi: 10.1097/COH.0000000000000585. [Epub ahead of print].
    Chamie G, Kamya MR, Petersen ML, Havlir DV. Read more
  8. Intermittent preventive treatment of malaria delivered to primary schoolchildren provided effective individual protection in Jinja, Uganda: secondary outcomes of a cluster-randomized trial (START-IPT).Malar J. 2019 Sep 18;18(1):318. doi: 10.1186/s12936-019-2954-0.
    Rehman AM, Maiteki-Sebuguzi C, Gonahasa S, Okiring J, Kigozi SP, Chandler CIR, Drakeley C, Dorsey G, Kamya MR, Staedke SG. Read more
  9. Pre-exposure Prophylaxis (PrEP) Uptake Among Older Individuals in Rural Western Kenya.J Acquir Immune Defic Syndr. 2019 Dec 1;82(4):e50-e53. doi: 10.1097/QAI.0000000000002150. No abstract available..
    Olilo WA, Petersen ML, Koss CA, Wafula E, Kwarisiima D, Kadede K, Clark TD, Cohen CR, Bukusi EA, Kamya MR, Charlebois ED, Havlir DV, Ayieko J; SEARCH Collaboration. Read more
  10. Pareto rules for malaria super-spreaders and super-spreading.Nat Commun. 2019 Sep 2;10(1):3939. doi: 10.1038/s41467-019-11861-y.
    Cooper L, Kang SY, Bisanzio D, Maxwell K, Rodriguez-Barraquer I, Greenhouse B, Drakeley C, Arinaitwe E, G Staedke S, Gething PW, Eckhoff P, Reiner RC Jr, Hay SI, Dorsey G, Kamya MR, Lindsay SW, Grenfell BT, Smith DL. Read more
  11. Is that a real oocyst? Insectary establishment and identification of Plasmodium falciparum oocysts in midguts of Anopheles mosquitoes fed on infected human blood in Tororo, Uganda.Malar J. 2019 Aug 27;18(1):287. doi: 10.1186/s12936-019-2922-8.
    Musiime AK, Okoth J, Conrad M, Ayo D, Onyige I, Rek J, Nankabirwa JI, Arinaitwe E, Kamya MR, Dorsey G, van Gemert GJ, Staedke SG, Drakeley C, Bousema T, Andolina C. Read more
  12. HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa.N Engl J Med. 2019 Jul 18;381(3):219-229. doi: 10.1056/NEJMoa1809866.
    Havlir DV, Balzer LB, Charlebois ED, Clark TD, Kwarisiima D, Ayieko J, Kabami J, Sang N, Liegler T, Chamie G, Camlin CS, Jain V, Kadede K, Atukunda M, Ruel T, Shade SB, Ssemmondo E, Byonanebye DM, Mwangwa F, Owaraganise A, Olilo W, Black D, Snyman K, Burger R, Getahun M, Achando J, Awuonda B, Nakato H, Kironde J, Okiror S, Thirumurthy H, Koss C, Brown L, Marquez C, Schwab J, Lavoy G, Plenty A, Mugoma Wafula E, Omanya P, Chen YH, Rooney JF, Bacon M, van der Laan M, Cohen CR, Bukusi E, Kamya MR, Petersen MRead more
  13. Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial.Lancet Infect Dis. 2019 Sep;19(9):962-972. doi: 10.1016/S1473-3099(19)30299-3. Epub 2019 Jul 12.
    Muhindo MK, Jagannathan P, Kakuru A, Opira B, Olwoch P, Okiring J, Nalugo N, Clark TD, Ruel T, Charlebois E, Feeney ME, Havlir DV, Dorsey G, Kamya MR. Read more
  14. Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial. Lancet HIV. 2019 Mar;6(3):e155-e163. doi: 10.1016/S2352-3018(18)30330-8. Epub 2019 Jan 16.
    Thirumurthy, Ndyabakira, Marson, Emperador, Kamya M4, Havlir, Kwarisiima, Chamie. Read more
  15. Men’s Beliefs About the Likelihood of Serodiscordance in Couples with an HIV-Positive Partner: Survey Evidence from Rural Uganda. AIDS Behav. 2019 May 9. doi: 10.1007/s10461-019-02531-7. [Epub ahead of print].
    Ndyabakira, Chamie, Emperador, Marson, Kamya, Havlir, Kwarisiima, Thirumurthy. Read more
  16. The prevalence of histologic acute chorioamnionitis among HIV infected pregnant women in Uganda and its association with adverse birth outcomes. PLoS One. 2019 Apr 11;14(4):e0215058. doi: 10.1371/journal.pone.0215058. eCollection 2019.
    Ategeka J, Wasswa R, Olwoch P, Kakuru A, Natureeba P, Muehlenbachs A, Kamya MR, Dorsey G, Rizzuto G Read more
  17. Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial. Lancet. 2019 Apr 6;393(10179):1428-1439. doi: 10.1016/S0140-6736(18)32224-4. Epub 2019 Mar 22.
    Kajubi R, Ochieng T, Kakuru A, Jagannathan P, Nakalembe M, Ruel T, Opira B, Ochokoru H, Ategeka J, Nayebare P, Clark TD, Havlir DV, Kamya MR, Dorsey G. Read more
  18. Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors. Malar J. 2019 Mar 12;18(1):76. doi: 10.1186/s12936-019-2716-z.
    Ocan M, Akena D, Nsobya S, Kamya MR, Senono R, Kinengyere AA, Obuku EA. Read more
  19. LLIN Evaluation in Uganda Project (LLINEUP): a cross-sectional survey of species diversity and insecticide resistance in 48 districts of Uganda. 2019 Mar 12;12(1):94. doi: 10.1186/s13071-019-3353-7.
    Lynd A, Gonahasa S, Staedke SG, Oruni A, Maiteki-Sebuguzi C, Dorsey G, Opigo J, Yeka A, Katureebe A, Kyohere M, Hemingway J, Kamya MR, Donnelly MJ. Read more
  20. K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors. Malar J. 2019 Mar 7;18(1):60. doi: 10.1186/s12936-019-2701-6.
    Ocan M, Akena D, Nsobya S, Kamya MR, Senono R, Kinengyere AA, Obuku E. Read more
  21. A Patient-Centered Multicomponent Strategy for Accelerated Linkage to Care Following Community-Wide HIV Testing in Rural Uganda and Kenya. J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):414-422.
    Ayieko J, Petersen ML, Charlebois ED, Brown LB, Clark TD, Kwarisiima D, Kamya MR, Cohen CR, Bukusi EA, Havlir DV, Van Rie A. Read more
  22. Prevalence and factors associated with asthma among adolescents and adults in Uganda: a general population based survey. BMC Public Health. 2019 Feb 22;19(1):227. doi: 10.1186/s12889-019-6562-2.
    Kirenga BJ, de Jong C, Katagira W, Kasozi S, Mugenyi L, Boezen M, van der Molen T, Kamya MR. Read more
  23. Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis. PLoS One. 2019 Jan 23;14(1):e0210126.
    Brown LB, Getahun M, Ayieko J, Kwarisiima D, Owaraganise A, Atukunda M, Olilo W, Clark T, Bukusi EA, Cohen CR, Kamya MR, Petersen ML, Charlebois ED, Havlir DV, Camlin CS. Read more
  24. Case Report: Birth Outcome and Neurodevelopment in Placental Malaria Discordant Twins.Am J Trop Med Hyg. 2019 Mar;100(3):552-555. doi: 10.4269/ajtmh.18-0659.
    Conroy AL, Bangirana P, Muhindo MK, Kakuru A, Jagannathan P, Opoka RO, Liechty EA, Nakalembe M, Kamya MR, Dorsey G, John CC. Read more
  1. Comparative effectiveness of novel nonmonetary incentives to promote HIV testing.AIDS. 2018 Jul 17;32(11):1443-1451. doi: 10.1097/QADGabriel Chamie, Elisabeth M. Schaffer, Alex Ndyabakira,Devy M. Emperador, Dalsone Kwarisiima, Carol S. Camlin, Diane V. Havlir, James G. Kahn, Moses R. Kamya and Harsha Thirumurthy Read more
  2. Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria. Antimicrobial agents and chemotherapy. 2016 Mar 1;60(3):1274-82.
    Nyunt MM, Nguyen VK, Kajubi R, Huang L, Ssebuliba J, Kiconco S, Mwima MW, Achan J, Aweeka F, Parikh S, Mwebaza N. Read more
  3. Antiretroviral choice for HIV impacts antimalarial exposure and treatment outcomes in Ugandan children. Clinical Infectious Diseases. 2016 May 3:ciw291.
    Parikh S, Kajubi R, Huang L, Ssebuliba J, Kiconco S, Gao Q, Li F, Were M, Kakuru A, Achan J, Mwebaza N, Aweka FT. Read more
  4. Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan Children. In Open Forum Infectious Diseases 2016 Oct 1 (Vol. 3, No. 4, p. ofw217). Oxford University Press.
    Kajubi R, Huang L, Were M, Kiconco S, Li F, Marzan F, Gingrich D, Nyunt MM, Ssebuliba J, Mwebaza N, Aweeka FT, Parikh S. Read more
  5. Strong correlation of lumefantrine concentrations in capillary and venous plasma from malaria patients. PLoS One. 2018 Aug 16;13(8):e0202082. doi: 10.1371/journal.pone.0202082. eCollection 2018. PMID:30114201.
    Huang L, Mwebaza N, Kajubi R, Marzan F, Forsman C, Parikh S, Aweeka FT. Read more
  6. LLIN Evaluation in Uganda Project (LLINEUP): factors associated with ownership and use of long-lasting insecticidal nets in Uganda: a cross-sectional survey of 48 districts.Malar J. 2018 Nov 13;17(1):421. doi: 10.1186/s12936-018-2571-3.
    Gonahasa S, Maiteki-Sebuguzi C, Rugnao S, Dorsey G, Opigo J, Yeka A, Katureebe A, Kyohere M, Lynd A, Hemingway J, Donnelly M, Kamya MR, Staedke SG. Read more
  7. In utero priming of highly functional effector T cell responses to human malaria.Sci Transl Med. 2018 Oct 17;10(463). pii: eaat6176. doi: 10.1126/scitranslmed.aat6176.
    Odorizzi PM, Jagannathan P, McIntyre TI, Budker R, Prahl M, Auma A, Burt TD, Nankya F, Nalubega M, Sikyomu E, Musinguzi K, Naluwu K, Kakuru A, Dorsey G, Kamya MR, Feeney ME. Read more
  8. K13-propeller gene polymorphisms in Plasmodium falciparum parasite population: a systematic review protocol of burden and associated factors.Syst Rev. 2018 Nov 17;7(1):199. doi: 10.1186/s13643-018-0866-7.
    Ocan M, Akena D, Nsobya S, Kamya MR, Senono R, Kinengyere AA, Obuku E. Read more
  9. Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the SEARCH Studys.AIDS. 2018 Sep 24;32(15):2179-2188.
    Shade SB, Osmand T, Luo A, Aine R, Assurah E, Mwebaza B, Mwai D, Owaraganise A, Mwangwa F, Ayieko J, Black D, Brown LB, Clark TD, Kwarisiima D, Thirumurthy H, Cohen CR, Bukusi EA, Charlebois ED, Balzer L, Kamya MR, Petersen ML, Havlir DV, Jain V. Read more
  10. Prevalence of chloroquine resistance alleles among Plasmodium falciparum parasites in countries affected by malaria disease since change of treatment policy: a systematic review protocol.Syst Rev. 2018 Jul 27;7(1):108.
    Ocan M, Akena D, Nsobya S, Kamya MR, Senono R, Kinengyere AA, Obuku EA.. Read more
  11. Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure.Elife. 2018 Jul 25;7. pii: e35832.
    Rodriguez-Barraquer I, Arinaitwe E, Jagannathan P, Kamya MR, Rosenthal PJ, Rek J, Dorsey G, Nankabirwa J, Staedke SG, Kilama M, Drakeley C, Ssewanyana I, Smith DL, Greenhouse B. Read more
  12. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.PLoS Med. 2018 Jul 17;15(7):e1002606.
    Jagannathan P, Kakuru A, Okiring J, Muhindo MK, Natureeba P, Nakalembe M, Opira B, Olwoch P, Nankya F, Ssewanyana I, Tetteh K, Drakeley C, Beeson J, Reiling L, Clark TD, Rodriguez-Barraquer I, Greenhouse B, Wallender E, Aweeka F, Prahl M, Charlebois ED, Feeney ME, Havlir DV, Kamya MR, Dorsey G. Read more
  13. Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda.Clin Infect Dis. 2018 Nov 28;67(12):1853-1860.
    Koss CA, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, Balzer LB, Plenty A, Sang N, Kabami J, Ruel TD, Black D, Camlin CS, Cohen CR, Bukusi EA, Clark TD, Charlebois ED, Petersen ML, Kamya MR, Havlir DV; SEARCH Collaboration. Read more
  1. Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda. J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):279-284. PMID: 27828878; PMCID: PMC5303140 [Available on 2018-03-01] Koss CA, Natureeba P, Kwarisiima D, Ogena M, Clark TD, Olwoch P, Cohan D, Okiring J, Charlebois ED, Kamya MR, Havlir DV. Read more
  2. Intermittent Preventive Treatment with Dihydroartemisinin-piperaquine for the Prevention of Malaria among HIV-infected Pregnant Women. J Infect Dis. 2017 Feb 22. doi: 10.1093/infdis/jix110. [Epub ahead of print]. PMID: 28329368; PMCID: PMC5853208 Natureeba P, Kakuru A, Muhindo M, Littmann E, Ochieng T, Ategeka J, Koss CA, Plenty A, Charlebois ED, Clark TD, Nzarubara B, Nakalembe M, Cohan D, Rizzuto G, Muehlenbachs A, Ruel T, Jagannathan P, Havlir DV, Kamya MR, Dorsey G.Read more
  3. Antiretroviral therapy with efavirenz accentuates pregnancy-associated reduction of dihydroartemisinin-piperaquine exposure during malaria chemoprevention. Clin Pharmacol Ther. 2017 Feb 10. doi: 10.1002/cpt.664. [Epub ahead of print]. PMID: 28187497; PMCID:PMC5546920 [Available on 2017-05-30] Kajubi R, Huang L, Jagannathan P, Chamankhah N, Were M, Ruel T, Koss CA, Kakuru A, Mwebaza N, Kamya M, Havlir D, Dorsey G, Rosenthal PJ, Aweeka FT. Read more
  4. Avidity of Anti-Malarial Antibodies Inversely Related to Transmission Intensity at Three Sites in Uganda. Malaria Journal 10;16(1):67. Ssewanyana I, Arinaitwe E, Nankabirwa JI, Yeka A, Sullivan R, Kamya MR, Rosenthal PJ, Dorsey G, Mayanja-Kizza H, Drakeley C, Greenhouse B, Tetteh KK. Read more
  5. A Method for the Concurrent Estimation of the Complexity of Infection and SNP Allele Frequency for Malaria Parasites. PLoS Comput Biol 2017; 13(1):e1005348. PMID: 28125584; PMCID: PMC5300274 Chang HH, Worby CJ, Yeka A, Nankabirwa J, Kamya MR, Staedke SG, Dorsey G, Murphy M, Neafsey DE, Jeffreys AE, Hubbart C, Rockett KA, Amato R, Kwiatkowski DP, Buckee C, Greenhouse B. THE REAL McCOIL: Read more
  6. Avidity of Antimalarial Antibodies Inversely Related to Transmission Intensity at Three Sites in Uganda. Malaria J 2017; 16(1):67. PMID: 28183299; PMCID: PMC5301436 Ssewanyana I, Arinaitwe E, Nankabirwa JI; Yeka A, Sullivan R; Kamya MR; Rosenthal PJ; Dorsey G; Mayanja-Kizza H; Drakeley C; Greenhouse B; Tetteh KA. Read more
  7. Resurgence of malaria following discontinuation of indoor residual spraying of insecticide in a previously high transmission intensity area of Uganda. Clin Infect Dis 2017; 65(3):453-60. PMID: 28369387; PMCID 5850037. Raouf S, Mpimbaza A, Kigozi R, Sserwanga A, Rubahika D, Katamba H, Lindsay SW, Kapella BK, Belay KA, Kamya MR, Staedke SG, Dorsey G. Read more
  8. Drug resistance mediating Plasmodium falciparum polymorphisms and clinical presentations of parasitaemic children in Uganda. Malar J 2017;16(1):125. PMID: 28327148; PMCID: PMC5361791 Tukwasibwe S, Tumwebaze P, Conrad M, Arinaitwe E, Kamya MR, Dorsey G, Nsobya SL, Greenhouse B, Rosenthal PJ. Read more
  9. Insecticide-induced leg loss does not eliminate biting and reproduction in Anopheles gambiae mosquitoes. Sci Rep 2017, 7:46674. PMID: 28440300; PMCID: PMC5404223 Isaacs AT, Lynd A, Donnelly MJ: Read more
  10. Plasmodium species infecting children presenting with malaria in Uganda. Am J Trop Med Hyg 2017;97(3):753-57. PMID: 28990911; PMCID 5590612 Asua V, Tukwasibwe S, Conrad M, Walakira A, Nankabirwa JI, Mugenyi L, Kamya MR, Nsobya SL, Rosenthal PJ:Read more
  11. Comparative prevalence of Plasmodium falciparum resistance-associated genetic polymorphisms in parasites infecting humans and mosquitoes in Uganda. Am J Trop Med Hyg 2017; [Epub ahead of print]. PMID: 29016309; PMCID 5817777 Conrad M, Mota D, Musiime A, Kilama M, Rek J, Kamya M, Dorsey G, Rosenthal PJ: Read more
  12. Performance of loop-mediated isothermal amplification for the identification of submicroscopic P. falciparum infection in Uganda. Am J Trop Med Hyg 2017; [Epub ahead of print]. PMID: 29016335; PMCID 5805042 Katrak S, Murphy M, Nayebare P, Rek J, Smith M, Arinaitwe E, Nankabirwa J, Kamya MR, Dorsey G, Rosenthal PR, Greenhouse, B. Read more
  13. Detection and quantitation of copy number variation in the voltage-gated sodium channel gene of the mosquito Culex quinquefasciatus. Sci Rep 2017;7(1):5821. PMID: 28725028; PMCID: PMC5517494 Martins WFS, Subramaniam K, Steen K, Mawejje H, Liloglou T, Donnelly MJ, Wilding CS. Read more
  14. Vδ2+ T cell response to malaria correlates with protection from infection but is attenuated with repeated exposure. Sci Rep 2017;7(1):11487. PMID: 28904345; PMCID: PMC5597587. Jagannathan P, Lutwama F, Boyle MJ, Nankya F, Farrington LA, McIntyre TI, Bowen K, Naluwu K, Nalubega M, Musinguzi K, Sikyomu E, Budker R, Katureebe A, Rek J, Greenhouse B, Dorsey G, Kamya MR, Feeney ME. Read more
  15. Impact of intermittent preventive treatment during pregnancy on Plasmodium falciparum drug resistance-mediating polymorphisms in Uganda. J Infect Dis 2017: [Epub ahead of print]. PMID: 28968782; PMCID 58853776 Conrad MD, Mota D, Foster M, Tukwasibwe S, Legac J, Tumwebaze P, Whalen M, Kakuru A, Nayebare P, Wallender E, Havlir DV, Jagannathan P, Huang L, Aweeka F, Kamya MR, Dorsey G, Rosenthal PJ. Read more
  16. Marked variation in prevalence of malaria-protective human genetic polymorphisms across Uganda. Infect Genet Evol 2017;55:281-87. PMID: 28939159; PMCID 5685907 Walakira A, Tukwasibwe S, Kiggundu M, Verra F, Kakeeto P, Ruhamyankaka E, Drakeley C, Dorsey G, Kamya MR, Nsobya SL, Rosenthal PJ. 1. Read more
  17. Opposing roles for TNF and IL10 production by CD4 T cells in human immunity to malaria. Frontiers in Immunology 2017. Boyle MJ, Jagannathan P, Bowen K, McIntyre TI, Vance HM, Farrington LA, Schwartz A, Nankya F, Naluwu K, Wamala S, Sikyomu E, Rek R, Greenhouse B, Arinaitwe E, Dorsey G, Kamya MR, Feeney ME. Read more
  18. Local selection in the presence of high levels of gene flow: Evidence of heterogeneous insecticide selection pressure across Ugandan Culex quinquefasciatus populations. Under review PLoS NTDs. 2017 Oct 3;11(10): e0005917 PMID: 28972985 PMCID: PMC5640252 Walter Fabricio Silva Martins, Craig Stephen Wilding, Keith Steen, Henry Mawejje, Tiago Rodrigues Antão, Martin James Donnelly. Read more
  19. Quantifying Signal and Noise in Malaria Vector Ecology. Submitted to Ecology Letters. Su Yun Kang, Laura Cooper, Kilama Maxwell, Moses Kamya, Stephen Lindsay, Grant Dorsey, Bryan Greenhouse, Isabelle Rodriguez-Barraquer, Peter W Gethhing, Robert C. Reiner, Bryan T. Grenfell, David L. Smith, and Donal Bisanzio. Read more
  20. Rules for Heterogeneous Malaria Transmission in Uganda. Submitted to PLoS Biology Laura Cooper, Su Yun Kang, Kilama Maxwell, Donal Bisanzio, Isabel Rodriguez-Barraquer, Bryan Greenhouse, Chris Drakele, Emmanuel Arinaitwe, Sarah Staedke, Peter W. Gething, Simon I. Hay, Grant Dorse, Moses Kamya, Steven W. Lindsay, Bryan T. Grenfell, David L. Smith. Power Laws and Pareto.Read more
  21. Rapid improvements to rural Ugandan housing and their association with malaria from intense to reduced transmission. Submitted to The Lancet Planetary Health in November 2017 John C Rek, MBChB; Victor Alegana, PhD; Emmanuel Arinaitwe , MBChB; Ewan Cameron, PhD; Moses R Kamya, PhD; Agaba Katureebe , MBChB; Steve W Lindsay, PhD; Maxwell Kilama; Sarah G Staedke, Md PhD; Jim Todd; Lucy Tusting. Read more
  22. Clinical consequences of submicroscopic malaria parasitemia in Uganda. Submitted to Malaria Journal MALJ-D-17-00746, 5th December 2017. Shereen Katrak; Patience Nayebare; John Rek; Emmanuel Arinaitwe; Joaniter I Nankabirwa; Moses Kamya; Grant Dorsey; Philip J Rosenthal; Bryan Greenhouse Read more
  23. Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study. The Lancet Infectious Diseases. 2017 Aug 25. Yoon, Christina Semitala Fred C., Atuhumuza Elly, Katende Jane, Mwebe Sandra, Asege Lucy, Armstrong Derek T., Andama Alfred O., Dowdy David W., Davis J. Luke, Huang Laurence, Kamya Moses. Read more
  24. Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes. Malaria Journal 2017 16:400 James Apollo Kapisi, Abel Kakuru, Prasanna Jagannathan, Mary K Muhindo, Paul Natureeba, Patricia Awori, Miriam Nakalembe, Richard Ssekitoleko, Peter Olwoch, John Ategeka, Patience Nayebare, Tamara D Clark, Gabrielle Rizzuto, Atis Muehlenbachs, Diane V Havlir, Moses R kamya, Grant Dorsey, Stephanie L Gaw. Read more
  1. Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children. Malar J. 2016 Apr 14;15(1):210. PMID: 27076184; PMCID: PMC4831156 Boivin MJ, Sikorskii A, Familiar-Lopez I, Ruisenor-Escudero H, Muhindo M, Kapisi J, Bigira V, Bass JK, Opoka RO, Nakasujja N, Kamya M, Dorsey G. Read more
  2. Vectorial capacity and vector control: reconsidering sensitivity to parameters for malaria elimination. Trans R Soc Trop Med Hyg 2016;110:107-17. PMID 26822603; PMID PMC4731004 Brady OJ, Godfray HCJ, Tatem AJ, Gething PW, Cohen JM, McKenzie FE, Perkins TA, Reiner RC, Tusting LS, Sinka ME, Moyes CL, Eckhoff PA, Scott TW, Lindsay SW, Hay SI, Smith DL. Read more
  3. Strengthening universal HIV ‘test-and-treat’ approaches with social science research. AIDS. 2016 Mar 27;30(6):969-70. PMID: 26959355; PMCID: PMC4794132 Camlin CS, Seeley J, Viljoen L, Vernooij E, Simwinga M, Reynolds L, Reis R, Plank R, Orne-Gliemann J, McGrath N, Larmarange J, Hoddinott G, Getahun M, Charlebois ED, Bond V. Read more
  4. Havlir DV, and the SEARCH Collaboration. Men “missing” from population based HIV testing: insights from qualitative research. AIDS Care 2016;28 Suppl 3:67-73. PMID: 27421053; PMID PMC5749410 Camlin CS, Ssemmondo E, Chamie G, El Ayadi AM, Kwarisiima D, Sang N, Kabami J, Charlebois ED, Petersen ML, Clark TD, Bukusi EA, Cohen CR, Kamya MR, Read more
  5. A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational study. Lancet HIV. 2016 Mar;3(3). PMID: 26939734, PMCID: PMC4780220 Chamie G, Clark TD, Kabami J, Kadede K, Ssemmondo E, Steinfeld R, Lavoy G, Kwarisiima D, Sang N, Jain V, Thirumurthy H, Liegler T, Balzer LB, Petersen ML, Cohen CR, Bukusi EA, Kamya MR, Havlir DV, Charlebois ED. Read more
  6. Cost and Efficiency of a Hybrid Mobile Multi-Diseases Testing Approach with High HIV Testing Coverage in East Africa. JAIDS 2016, in press. Chang W, Chamie G, Mwai D, Clark TD, Thirumurthy H, Charlebois ED, Petersen M, Kabami J, Ssemmondo E, Kadede K, Kwarisiima D, Sang N, Bukusi EA, Cohen CR, Kamya M, Havlir DV, Kahn JG. Read more
  7. The potential to expand antiretroviral therapy by improving health facility efficiency: evidence from Kenya, Uganda, and Zambia. BMC Med. 2016 Jul 20;14(1):108. PMID: 27439621; PMCID: PMC4952151 Di Giorgio L, Moses MW, Fullman N, Wollum A, Conner RO, Achan J, Achoki T, Bannon KA, Burstein R, Dansereau E, DeCenso B, Delwiche K, Duber HC, Gakidou E, Gasasira A, Haakenstad A, Hanlon M, Ikilezi G, Kisia C, Levine AJ, Maboshe M, Masiye F, Masters SH, Mphuka C, Njuguna P, Odeny TA, Okiro EA, Roberts DA, Murray CJ, Flaxman AD. Read more
  8. Identification, Validation, and Application of Molecular Diagnostics for Insecticide Resistance in Malaria Vectors. Trends Parasitol 2016;32:197-206. PMID: 26750864; PMCID PMC4767538 Donnelly MJ, Isaacs AT, Weetman D. Read more
  9. Evaluating facility-based antiretroviral therapy programme effectiveness: a pilot study comparing viral load suppression and retention rates. Trop Med Int Health. 2016 Jun;21(6):750-8. doi: 10.1111/tmi.12694. Epub 2016 Apr 20. Duber HC, Roberts DA, Ikilezi G, Fullman N, Gasasira A, Gakidou E, Haakenstad A, J Levine A, Achan J. Read more
  10. Frequent Malaria Drives Progressive Vd2 T-Cell Loss, Dysfunction, and CD16 Up-regulation During Early Childhood. J Infect Dis. 2016 May 1;213(9):1483-90. PMID: 26667315; PMCID: PMC4813738 Farrington LA, Jagannathan P, McIntyre TI, Vance HM, Bowen K, Boyle MJ, Nankya F, Wamala S, Auma A, Nalubega M, Sikyomu E, Naluwu K, Bigira V, Kapisi J, Dorsey G, Kamya MR, Feeney ME. Read more
  11. Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis. Open Forum Infect Dis. 2016 May 12;3(2):ofw068. PMID: 27186589: PMC4866550 Hanrahan CF, Haguma P, Ochom E, Kinera I, Cobelens F, Cattamanchi A, Davis L, Katamba A, Dowdy D. Read more
  12. Effective Antimalarial Chemoprevention in Childhood Enhances the Quality of CD4+ T Cells and Limits Their Production of Immunoregulatory Interleukin 10. J Infect Dis. 2016 Jul 15;214(2):329-38. PMID: 27067196: PMC4918829 Jagannathan P, Bowen K, Nankya F, McIntyre TI, Auma A, Wamala S, Sikyomu E, Naluwu K, Nalubega M, Boyle MJ, Farrington LA, Bigira V, Kapisi J, Aweeka F, Greenhouse B, Kamya M, Dorsey G, Feeney ME. Read more
  13. Increased adolescent HIV testing with a hybrid mobile strategy in Uganda and Kenya. AIDS. 2016 Jun 1. [Epub ahead of print] PMID: 27258399: PMC5007167 Kadede K, Ruel T, Kabami J, Ssemmondo E, Sang N, Kwarisiima D, Bukusi E, Cohen CR, Liegler T, Clark TD, Charlebois ED, Petersen ML, Kamya MR,Havlir DV, Chamie G; SEARCH team. Read more
  14. Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy. N Engl J Med. 2016 Mar 10;374(10):928-39. PMID: 26962728: PMC4847718 Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, Nakalembe M, Opira B, Olwoch P, Ategeka J, Nayebare P, Clark TD, Feeney ME, Charlebois ED, Rizzuto G, Muehlenbachs A, Havlir DV, Kamya MR, Dorsey G. Read more
  15. Empiric TB Treatment of Severely Ill Patients With HIV and Presumed Pulmonary TB Improves Survival. J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):297-303. PMID: 26918546: PMC5108656 Katagira W, Walter ND, Den Boon S, Kalema N, Ayakaka I, Vittinghoff E, Worodria W, Cattamanchi A, Huang L, Davis JL. Read more
  16. Community-wide Prevalence of Malaria Parasitemia in HIV-Infected and Uninfected Populations in a High-Transmission Setting in Uganda. J Infect Dis. 2016 Feb 10. PMID: 26908725, PMCID: PMC4878723 Katrak S, Day N, Ssemmondo E, Kwarisiima D, Midekisa A, Greenhouse B, Kamya M, Havlir D, Dorsey G. Read more
  17. Brief Report: Food Insufficiency Is Associated With Lack of Sustained Viral Suppression Among HIV-Infected Pregnant and Breastfeeding Ugandan Women. J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):310-5. PMID: 26397935; PMCID: PMC4752388 Koss CA, Natureeba P, Nyafwono D, Plenty A, Mwesigwa J, Nzarubara B, Clark TD, Ruel TD, Achan J, Charlebois ED, Cohan D, Kamya MR, Havlir DV, Young SL. Read more
  18. Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda. PLoS One. 2016 May 27;11(5). PMID: 27232186, PMCID: PMC4883789 Kwarisiima D, Balzer L, Heller D, Kotwani P, Chamie G, Clark T, Ayieko J, Mwangwa F, Jain V, Byonanebye D, Petersen M, Havlir D, Kamya MR. Read more
  19. “How can I tell?” Consequences of HIV status disclosure among couples in eastern African communities in the context of an ongoing HIV “test-and-treat” trial. AIDS Care 2016;28 Suppl 3:59-66. PMID: 27421052: PMCID5751752 Maeri I, El Ayadi A, Getahun M, Charlebois ED, Akatukwasa C, Tumwebaze D, Itiakorit H, Owino L, Kwarisiima D, Ssemmondo E, Sang N, Kabami J, Clark TD, Petersen ML, Cohen CR, Bukusi EA, Kamya MR, Havlir DV, Camlin CS, and the SEARCH Collaboration. Read more
  20. Tuberculosis Infection in Early Childhood and the Association with HIV-exposure in HIV-uninfected Children in Rural Uganda. Pediatr Infect Dis J. 2016 May;35(5):524-9. PMID: 26771662; PMCID: PMC4829461 Marquez C, Chamie G, Achan J, Luetkemeyer AF, Kyohere M, Okiring J, Dorsey G, Kamya MR, Charlebois ED, Havlir DV. Read more
  21. Intermittent preventive treatment with dihydroartemisinin-piperaquine in Ugandan schoolchildren selects for Plasmodium falciparum transporter polymorphisms that modify drug sensitivity. Antimicrob Agents Chemother. 2016 Jul 11. PMID: 27401569: PMCID5038325 Nankabirwa JI, Conrad MD, Legac J, Tukwasibwe S, Tumwebaze P, Wandera B, Brooker SJ, Staedke SG, Kamya MR, Nsobya SL, Dorsey G, Rosenthal PJ. Read more
  22. Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children. Clin Infect Dis. 2016 Aug 1;63(3):414-22. PMID: 27143666: PMCID4946019 Parikh S, Kajubi R, Huang L, Ssebuliba J, Kiconco S, Gao Q, Li F, Were M, Kakuru A, Achan J, Mwebaza N, Aweeka FT. Read more
  23. Quantifying heterogeneous malaria exposure and clinical protection in a cohort of Ugandan children. J Infect Dis. 2016 Aug 1. PMID: 27481862: PMCID5021229 Rodriguez-Barraquer I, Arinaitwe E, Jagannathan P, Boyle MJ, Tappero J, Muhindo M, Kamya MR, Dorsey G, Drakeley C, Ssewanyana I, Smith DL, Greenhouse B. Read more
  24. Identifying Malaria Transmission Foci for Elimination Using Human Mobility Data. PLoS Comput Biol 2016;12:e1004846. PMID 27043913; PMCID4820264 Ruktanonchai NW, DeLeenheer P, Tatem AJ, Alegana VA, Caughlin TT, zu Erbach-Schoenberg E, Lourenco C, Ruktanonchai CW, Smith DL. Read more
  25. Immune Response and Mortality Risk Relate to Distinct Lung Microbiomes in HIV-Pneumonia Patients. Am J Respir Crit Care Med. 2016 Jul 22. PMID: 27447987: PMCID5214918 Shenoy MK, Iwai S, Lin DL, Worodria W, Ayakaka I, Byanyima P, Kaswabuli S, Fong S, Stone S, Chang E, Davis JL, Faruqi AA, Segal MR, Huang L, Lynch SV. Read more
  26. Population-based active TB case finding during large-scale mobile HIV testing campaigns in rural Uganda. JAIDS 2016, in press. Ssemmondo E, Mwangwa F, Kironde JL, Kwarisiima D, Clark TD, Marquez C, Charlebois ED, Petersen ML, Kamya MR, Havlir DV, Chamie G and the SEARCH Collaboration. Read more
  27. The Impact of an Intervention to Improve Malaria Care in Public Health Centers on Health Indicators of Children in Tororo, Uganda (PRIME): A Cluster-Randomized Trial. Am J Trop Med Hyg. 2016 Jun 6. PMID: 27273646: PMCID4973182 Staedke SG, Maiteki-Sebuguzi C, DiLiberto DD, Webb EL, Mugenyi L, Mbabazi E, Gonahasa S, Kigozi SP, Willey BA, Dorsey G, Kamya MR, Chandler CI. Read more
  28. B cell sub-types following acute malaria and associations with clinical immunity. Malar J 2016; 15:139. PMID 26939776; PMCID PMC4778296 Sullivan RT, Ssewenyana I, Wamala S, Nankya F, Jagannathan P, Tappero JW, Mayanja-Kizza H, Muhindo MK, Arinaitwe E, Kamya M, Dorsey G, Feeney ME, Riley EM, Drakeley CJ, Greenhouse B. Read more
  29. Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria. J Infect Dis. 2016 Jul 28. PMID: 27471317: PMCID5034953 Tchaparian E, Sambol NC, Arinaitwe E, McCormack SA, Bigira V, Wanzira H, Muhindo M, Creek DJ, Sukumar N, Blessborn D, Tappero JW, Kakuru A, Bergqvist Y, Aweeka FT, Parikh S. Read more
  30. Expectations about future health and longevity in Kenyan and Ugandan communities receiving a universal test-and-treat intervention. AIDS Care 2016;28 Suppl 3:90-8. PMID: 27421056: PMCID5443252 Thirumurthy H, Jakubowski A, Camlin C, Kabami J, Ssemmondo E, Elly A, Mwai D, Clark T, Cohen C, Bukusi E, Kamya M, Petersen M, Havlir D, Charlebois ED. Read more
  31. Measuring socioeconomic inequalities in relation to malaria risk: A Comparison of Metrics in Rural Uganda. Am J Trop Med Hyg 2016;94(3):650-8. PMID: 26811432; PMCID: PMC 4775903 Tusting LS, Rek JC, Arinaitwe E, Staedke SG, Kamya MR, Bottomley C, Johnston D, Lines J, Dorsey G, Lindsay SW. Read more
  32. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data. BMC Med. 2016 May 24;14:79. PMID: 27221542: PMCID4879753 WWARN Gametocyte Study Group. Read more
  33. Artesunate/amodiaquine versus artemether/lumefantrine for the treatment of uncomplicated malaria in Uganda: a randomized trial. J Infect Dis 2016;213:1134-42. PMID: 26597254; PMCID: PMCID4836737 Yeka A, Kigozi R, Conrad M, Lugemwa M, Okui P, Katureebe C, Belay K, Kapella BK, Chang MA, Kamya MR, Staedke SG, Dorsey G, Rosenthal PJ. Read more
  1. Entomological Monitoring and Evaluation: Diverse Transmission Settings of ICEMR Projects Will Require Local and Regional Malaria Elimination Strategies. Am J Trop Med Hyg. 2015 Aug 10. pii: 15-0009. Conn JE, Norris DE, Donnelly MJ, Beebe NW, Burkot TR, Coulibaly MB, Chery L, Eapen A, Keven JB, Kilama M, Kumar A, Lindsay SW, Moreno M, Quinones M,Reimer LJ, Russell TL, Smith DL, Thomas MB, Walker ED, Wilson ML, Yan G.Read more
  2. Anti-malarial prescription practices among children admitted to six public hospitals in Uganda from 2011 to 2013. Malar J. 2015 Aug 27;14(1):331. doi: 10.1186/s12936-015-0851-8 Sserwanga A, Sears D, Kapella BK, Kigozi R, Rubahika D, Staedke SG, Kamya M, Yoon SS, Chang MA, Dorsey G, Mpimbaza A. Read more
  3. The effect of malnutrition on the pharmacokinetics and virologic outcomes of lopinavir, efavirenz and nevirapine in food insecure HIV-infected children in Tororo, Uganda. Pediatr Infect Dis J. 2015 Mar;34(3):e63-70. doi: 10.1097/INF.0000000000000603. PMID: 25742090: PMCID4351793 Bartelink IH, Savic RM, Dorsey G, Ruel T, Gingrich D, Scherpbier HJ, Capparelli E, Jullien V, Young SL, Achan J, Plenty A, Charlebois E, Kamya M, Havlir D, Aweeka F. Read more
  4. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015 Feb 2. pii: jiv054. [Epub ahead of print] PMID: 25646355: PMCID4539911 Boyle MJ, Jagannathan P, Bowen K, McIntyre TI, Vance HM, Farrington LA, Greenhouse B, Nankya F, Rek J, Katureebe A, Arinaitwe E, Dorsey G, Kamya MR, Feeney ME. Read more
  5. Health worker perspectives on barriers to delivery of routine tuberculosis diagnostic evaluation services in Uganda: a qualitative study to guide clinic-based interventions. BMC Health Serv Res. 2015 Jan 22;15:10. doi: 10.1186/s12913-014-0668-0. PMID: 25609495: PMCID4307676 Cattamanchi A, Miller CR, Tapley A, Haguma P, Ochom E, Ackerman S, Davis JL, Katamba A, Handley MA. Read more
  6. Identifying locations of recent TB transmission in rural Uganda: a multidisciplinary approach. Trop Med Int Health. 2015 Apr;20(4):537-45. doi: 10.1111/tmi.12459. Epub 2015 Feb 4. PMID: 25583212 Chamie G, Wandera B, Marquez C, Kato-Maeda M, Kamya MR, Havlir DV, Charlebois ED. Read more
  7. Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women. AIDS. 2015 Jan 14;29(2):183-91. doi: 10.1097/QAD.0000000000000531. PMID: 25426808: PMCID4428759 Cohan D, Natureeba P, Koss CA, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Gandhi M, Clark TD, Nzarubara B, Achan J, Ruel T, Kamya MR, Havlir DV. Read more
  8. Lack of artemisinin resistance in Plasmodium falciparum in Uganda based on parasitological and molecular assays. Antimicrob Agents Chemother. 2015 Jun 1. pii: AAC.00921-15. [Epub ahead of print] PMID: 26033725 Cooper RA, Conrad MD, Watson QD, Huezo SJ, Ninsiima H, Tumwebaze P, Nsobya SL, Rosenthal PJ. Read more
  9. GMalaria genotyping for epidemiologic surveillance. Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):6782-3. doi: 10.1073/pnas.1507727112. Epub 2015 May 27. PMID: 26016526: PMCID4460462 reenhouse B, Smith DL. Read more
  10. Malaria transmission, infection, and disease at three sites with varied transmission intensity in Uganda: implications for malaria control. Am J Trop Med Hyg. 2015 May 6;92(5):903-12. doi: 10.4269/ajtmh.14-0312. Epub 2015 Mar 16. PMID: 25778501: PMCID4426576 Kamya MR, Arinaitwe E, Wanzira H, Katureebe A, Barusya C, Kigozi SP, Kilama M, Tatem AJ, Rosenthal PJ, Drakeley C, Lindsay SW, Staedke SG, Smith DL, Greenhouse B, Dorsey G. Read more
  11. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens. Malar J. 2015 Feb 5;14(1):53. doi: 10.1186/s12936-015-0583-9. PMID: 25652127: PMCID4333162 Kapisi J, Bigira V, Clark T, Kinara S, Mwangwa F, Achan J, Kamya M, Soremekun S, Dorsey G. Read more
  12. Bacteremia Among Febrile Ugandan Children Treated with Antimalarials Despite a Negative Malaria Test. Am J Trop Med Hyg. 2015 Jun 8. pii: 14-0494. [Epub ahead of print] PMID: 26055736: PMCID4530747 Kibuuka A, Byakika-Kibwika P, Achan J, Yeka A, Nalyazi JN, Mpimbaza A, Rosenthal PJ, Kamya MR. Read more
  13. International HIV-associated Opportunistic Pneumonias (IHOP) Study. A Clinical Predictor Score for 30-Day Mortality among HIV-Infected Adults Hospitalized with Pneumonia in Uganda. PLoS One. 2015 May 11;10(5):e0126591. doi: 10.1371/journal.pone.0126591. eCollection 2015. PMID: 25962069: PMCID4427329 Koss CA, Jarlsberg LG, den Boon S, Cattamanchi A, Davis JL, Worodria W, Ayakaka I, Sanyu I, Huang L; Read more
  14. Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women.. AIDS. 2015 Apr 24;29(7):825-30. doi: 10.1097/QAD.0000000000000619. PMID: 25985404AIDS. PMCID443838773 Koss CA, Natureeba P, Mwesigwa J, Cohan D, Nzarubara B, Bacchetti P, Horng H, Clark TD, Plenty A, Ruel TD, Achan J, Charlebois ED, Kamya MR, Havlir DV, Gandhi M. Read more
  15. Comparison of routine health management information system versus enhanced inpatient malaria surveillance for estimating the burden of malaria among children admitted to four hospitals in Uganda. Am J Trop Med Hyg. 2015 Jan;92(1):18-21. doi: 10.4269/ajtmh.14-0284. Epub 2014 Nov 24. PMID: 25422396: PMCID4347377 Mpimbaza A, Miles M, Sserwanga A, Kigozi R, Wanzira H, Rubahika D, Nasr S, Kapella BK, Yoon SS, Chang M, Yeka A, Staedke SG, Kamya MR, Dorsey G. Read more
  16. Challenging logics of complex intervention trials: community perspectives of a health care improvement intervention in rural Uganda. Soc Sci Med. 2015 Apr;131:10-7. doi: 10.1016/j.socscimed.2015.02.032. Epub 2015 Feb 20. PMID: 25748110 Okwaro FM, Chandler CI, Hutchinson E, Nabirye C, Taaka L, Kayendeke M, Nayiga S, Staedke SG. Read more
  17. The Effect of Storage and Extraction Methods on Amplification of Plasmodium falciparum DNA from Dried Blood Spots. Am J Trop Med Hyg. 2015 May 6;92(5):922-5. doi: 10.4269/ajtmh.14-0602. Epub 2015 Mar 9. PMID: 25758652: PMCID4426578 Schwartz A, Baidjoe A, Rosenthal PJ, Dorsey G, Bousema T, Greenhouse B. Read more
  18. Quality of Inpatient Pediatric Case Management for Four Leading Causes of Child Mortality at Six Government-Run Ugandan Hospitals. PLoS One. 2015 May 19;10(5):e0127192. doi: 10.1371/journal.pone.0127192. eCollection 2015. PMID: 25992620: PMCID4437786 Sears D, Mpimbaza A, Kigozi R, Sserwanga A, Chang MA, Kapella BK, Yoon S, Kamya MR, Dorsey G, Ruel T. Read more
  19. Poor Housing Construction Associated with Increased Malaria Incidence in a Cohort of Young Ugandan Children. Am J Trop Med Hyg. 2015 Apr 13. pii: 14-0828. [Epub ahead of print] PMID: 25870429: PMCID4458827 Snyman K, Mwangwa F, Bigira V, Kapisi J, Clark TD, Osterbauer B, Greenhouse B, Sturrock H, Gosling R, Liu J, Dorsey G. Read more
  20. FCRL5 Delineates Functionally Impaired Memory B Cells Associated with Plasmodium falciparum Exposure. PLoS Pathog. 2015 May 19;11(5):e1004894. doi: 10.1371/journal.ppat.1004894. eCollection 2015 May. PMID: 25993340: PMCID4438005 Sullivan RT, Kim CC, Fontana MF, Feeney ME, Jagannathan P, Boyle MJ, Drakeley CJ, Ssewanyana I, Nankya F, Mayanja-Kizza H, Dorsey G, Greenhouse B. Read more
  21. Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from Ugandan children. Antimicrob Agents Chemother. 2015 Mar 9. pii: AAC.05141-14. [Epub ahead of print] PMID: 25753626: PMCID4432194 Tumwebaze P, Conrad MD, Walakira A, LeClair N, Byaruhanga O, Nakazibwe C, Kozak B, Bloome J, Okiring J, Kakuru A, Bigira V, Kapisi J, Legac J, Gut J, Cooper RA, Kamya MR, Havlir DV, Dorsey G, Greenhouse B, Nsobya SL, Rosenthal PJ. Read more
  22. The evidence for improving housing to reduce malaria: a systematic review and meta-analysis. Malar J. 2015 Jun 9;14:209. doi: 10.1186/s12936-015-0724-1. PMID: 26055986 :PMCID4460721 Tusting LS, Ippolito MM, Willey BA, Kleinschmidt I, Dorsey G, Gosling RD, Lindsay SW. Read more
  23. Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis. J Infect Dis. 2015 Mar 11. pii: jiv149. [Epub ahead of print] PMID: 25762787:PMCID4548467 Walter ND, Dolganov GM, Garcia BJ, Worodria W, Andama A, Musisi E, Ayakaka I, Van TT, Voskuil MI, de Jong BC, Davidson RM, Fingerlin TE, Kechris K, Palmer C, Nahid P, Daley CL, Geraci M, Huang L, Cattamanchi A, Strong M, Schoolnik GK, Davis JL. Read more
  24. house structure and the risk of malaria in Uganda. PLoS One. 2015 Jan 30;10(1):e0117396. doi: 10.1371/journal.pone.0117396. eCollection 2015. PMID: 25635688: PMCID4311957 Wanzira H, Tusting LS, Arinaitwe E, Katureebe A, Maxwell K, Rek J, Bottomley C, Staedke SG, Kamya M, Dorsey G, Lindsay SW. Mind the gap: Read more
  1. Factors associated with malaria parasitemia, anemia and serological responses in a spectrum of epidemiological settings in Uganda. PLoS One. 2015 Mar 13;10(3):e0118901. doi: 10.1371/journal.pone.0118901. eCollection 2015. PMID: 25768015:PMCID4358889 Yeka A, Nankabirwa J, Mpimbaza A, Kigozi R, Arinaitwe E, Drakeley C, Greenhouse B, Kamya MR, Dorsey G, Staedke SG. Read more
  2. Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children. PLoS One. 2014 Dec 1;9(12):e113311. doi: 10.1371/journal.pone.0113311. eCollection 2014. PMID: 25436614: PMCID4249977 Yeka A, Lameyre V, Afizi K, Fredrick M, Lukwago R, Kamya MR, Talisuna AO. Read more
  3. Community case management of malaria: exploring support, capacity and motivation of community medicine distributors in Uganda. Health Policy Plan. 2014 May 10. PMID: 24816572:PMCID4385822 Banek K, Nankabirwa J, Maiteki-Sebuguzi C, Diliberto D, Taaka L, Chandler CI, Staedke SG. Read more
  4. Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence. Malar J. 2014 Jan 6;13:7. doi: 10.1186/1475-2875-13-7. Review. PMID: 24386988:PMCID3893456 Banek K, Lalani M, Staedke SG, Chandramohan D. Read more
  5. Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young ugandan children: a randomized controlled trial. PLoS Med. 2014 Aug 5;11(8):e1001689. doi: 10.1371/journal.pmed.1001689. eCollection 2014 Aug. PMID: 25093754 :PMCID4122345 Bigira V, Kapisi J, Clark TD, Kinara S, Mwangwa F, Muhindo MK, Osterbauer B, Aweeka FT, Huang L, Achan J, Havlir DV, Rosenthal PJ, Kamya MR, Dorsey G. Read more
  6. Uptake of community-based HIV testing during a multi-disease health campaign in rural Uganda. PLoS One. 2014 Jan 2;9(1):e84317. doi: 10.1371/journal.pone.0084317. eCollection 2014. PMID: 24392124 :PMCID3879307 Chamie G, Kwarisiima D, Clark TD, Kabami J, Jain V, Geng E, Balzer LB, Petersen ML, Thirumurthy H, Charlebois ED, Kamya MR, Havlir DV. Read more
  7. Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women. AIDS. 2015 Jan 14;29(2):183-91. doi: 10.1097/QAD.0000000000000531. PMID: 25426808 :PMCID4428759 Cohan D, Natureeba P, Koss CA, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Gandhi M, Clark TD, Nzarubara B, Achan J, Ruel T, Kamya MR, Havlir DV. Read more
  8. Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children. PLoS One. 2014;9:e105690. PMID: 25144768:PMCID4140830 Conrad MD, Bigira V, Kapisi J, Muhindo M, Kamya MR, Havlir DV, Dorsey G, Rosenthal PJ. Read more
  9. Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children. Journal of Infectious Diseases 2014. In press. PMID: 24610872:PMCID4110461 Conrad M, LeClair N, Arinaitwe E, Wanzira H, Kakuru A, Bigira V,Muhindo M, Kamya MR, Tappero JW, Greenhouse B, Dorsey G, Rosenthal PJ. Read more
  10. Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trial. Am J Respir Crit Care Med. 2014 Jun 15;189(12):1551-9. doi: 10.1164/rccm.201311-1974OC. PMID: 24869625:PMCID4226012 Davis JL, Kawamura LM, Chaisson LH, Grinsdale J, Benhammou J, Ho C, Babst A, Banouvong H, Metcalfe JZ, Pandori M, Hopewell PC, Cattamanchi A. Read more
  11. Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial. Lancet Infect Dis. 2014 Feb;14(2):130-9. doi: 10.1016/S1473-3099(13)70268-8. Epub 2013 Nov 13. PMID: 24239324 Eziefula AC, Bousema T, Yeung S, Kamya M, Owaraganise A, Gabagaya G, Bradley J, Grignard L, Lanke KH, Wanzira H, Mpimbaza A, Nsobya S, White NJ, Webb EL, Staedke SG, Drakeley C. Read more
  12. Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine. Antimicrob Agents Chemother. 2014 Aug;58(8):4971-3. doi: 10.1128/AAC.02889-14. Epub 2014 Jun 9. PMID: 24913169 Eziefula AC, Pett H, Grignard L, Opus S, Kiggundu M, Kamya MR, Yeung S, Staedke SG, Bousema T, Drakeley C. Read more
  13. Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial. Lancet Glob Health. 2014 Dec;2(12):e727-36. doi: 10.1016/S2214-109X(14)70329-8. PMID: 25433628 Homsy J, Dorsey G, Arinaitwe E, Wanzira H, Kakuru A, Bigira V, Muhindo M, Kamya MR, Sandison TG, Tappero JW. Read more
  14. Point of care testing for malaria using LAMP, loop mediated isothermal amplification. J Infect Dis. 2014 Oct 15;210(8):1167-9. doi: 10.1093/infdis/jiu253. Epub 2014 May 1. PMID: 24795471 Hsiang MS, Greenhouse B, Rosenthal PJ. Read more
  15. The lung microbiome of Ugandan HIV-infected pneumonia patients is compositionally and functionally distinct from that of San Franciscan patients. PLoS One. 2014 Apr 21;9(4):e95726. doi: 10.1371/journal.pone.0095726. eCollection 2014. PMID: 24752365 Iwai S, Huang D, Fong S, Jarlsberg LG, Worodria W, Yoo S, Cattamanchi A, Davis JL, Kaswabuli S, Segal M, Huang L, Lynch SV. Read more
  16. JIFNγ/IL-10 Co-producing Cells Dominate the CD4 Response to Malaria in Highly Exposed Children. PLoS Pathogens 2014; 10(1): e1003864. doi:10.1371/journal.ppat.1003864 agannathan P, Eccles-James I, Bowen K, Nankya F, Auma A, Wamala S, Ebusu C, Muhindo MK, Arinaitwe E, Briggs J, Greenhouse B, Tappero JW, Kamya MR, Dorsey G, Feeney ME. Read more
  17. Loss and dysfunction of Vδ2+ γδ T cells is associated with clinical tolerance to malaria. Sci Transl Med. 2014;6(251). Jagannathan, P, Kim CC, Greenhouse B, Nankya F, Bowen K, Eccles-James I, Muhindo MK, Arinaitwe E, Tappero JW, Kamya MR, Dorsey G, Feeney, ME.  Read more
  18. IFNγ responses to pre-erythrocytic and blood-stage malaria antigens exhibit differential associations with past exposure and subsequent protection. J Infect Dis. 2014 Dec 17. pii: jiu814. [Epub ahead of print] PMID: 25520427 Jagannathan P, Nankya F, Stoyanov C, Eccles-James I, Sikomyu E, Naluwu K, Wamala S, Nalubega M, Briggs J, Bowen K, Bigira V, Kapisi J, Kamya MR, Dorsey G, Feeney ME. Read more
  19. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda. AIDS. 2014 Sep 24;28(15):2241-9. doi: 10.1097/QAD.0000000000000401. PMID: 25022596 Jain V, Byonanebye DM, Amanyire G, Kwarisiima D, Black D, Kabami J, Chamie G, Clark TD, Rooney JF, Charlebois ED, Kamya MR, Havlir DV; SEARCH Collaboration. Read more
  20. Changes in population HIV RNA levels in Mbarara, Uganda, during scale-up of HIV antiretroviral therapy access. J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):327-32. doi: 10.1097/QAI.0000000000000021. PMID: Jain V, Byonanebye DM, Liegler T, Kwarisiima D, Chamie G, Kabami J, Petersen ML, Balzer LB, Clark TD, Black D, Thirumurthy H, Geng EH, Charlebois ED, Amanyire G, Kamya MR, Havlir DV; SEARCH Collaboration. Read more
  21. Modeling within-host effects of drugs on Plasmodium falciparum transmission and prospects for malaria elimination. PLoS Comput Biol. 2014 Jan;10(1):e1003434. PMID: 24465196 Johnston GL, Gething PW, Hay SI, Smith DL, Fidock DA. Read more
  22. Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children.  Clin Infect Dis. 2014 Aug;59(3):446-53. doi: 10.1093/cid/ciu286. Epub 2014 Apr 23. PMID: 24759826 Read more
  23. Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.  AIDS. 2014 Nov 28;28(18):2701-2709.PMID: 25493596 Kamya MR, Kapisi J, Bigira V, Clark TD, Kinara S, Mwangwa F, Muhindo MK, Kakuru A, Aweeka FT, Huang L, Jagannathan P, Achan J, Havlir DV, Rosenthal PJ, Dorsey G. Read more
  24. Estimating the annual entomological inoculation rate for Plasmodium falciparum transmitted by Anopheles gambiae s.l. using three sampling methods in three sites in Uganda. Malaria Journal 2014;13(1):111. PMID: 24656206 Kilama M, Smith DL, Hutchinson R, Kigozi R, Lavoy G, Kamya MR, Staedke SG, Donnelly MJ, Drakeley C, Greenhouse B, Dorsey G, Lindsay SW. Read more
  25. Acceptability and feasibility of serial HIV antibody testing during pregnancy/postpartum and male partner testing in Tororo, Uganda. AIDS Care. 2014;26(3):360-6. doi: 10.1080/09540121.2013.824536. Epub 2013 Aug 2. PMID: 23909832 Kim LH, Arinaitwe E, Nzarubara B, Kamya MR, Clark TD, Okong P, Charlebois ED, Havlir DV, Cohan D. Read more
  26. Determination of the antimalarial drug piperaquine in small volume pediatric plasma samples by LC-MS/MS. Bioanalysis. 2014 Dec;6(23):3081-9. doi: 10.4155/bio.14.254. PMID: 25529877 Kjellin LL, Dorsey G, Rosenthal PJ, Aweeka F, Huang L. Read more
  27. Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy. J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):128-35. doi: 10.1097/QAI.0000000000000281. PMID: 25072616 Koss CA, Natureeba P, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Clark TD, Achan J, Ruel T, Nzarubara B, Kamya MR, Havlir DV, Cohan D. Read more
  28. Evaluating linkage to care for hypertension after community-based screening in rural Uganda. Trop Med Int Health. 2014 Apr;19(4):459-68. doi: 10.1111/tmi.12273. Epub 2014 Feb 3. PMID: 24495307 Kotwani P, Balzer L, Kwarisiima D, Clark TD, Kabami J, Byonanebye D, Bainomujuni B, Black D, Chamie G, Jain V, Thirumurthy H, Kamya MR, Geng EH, Petersen ML, Havlir DV, Charlebois ED; SEARCH Collaboration. Read more
  29. Assessing the quality of tuberculosis evaluation for children with prolonged cough presenting to routine community health care settings in rural Uganda. PLoS One. 2014 Aug 29;9(8):e105935. doi: 10.1371/journal.pone.0105935. eCollection 2014. PMID: 25170875 Marquez C, Davis JL, Katamba A, Haguma P, Ochom E, Ayakaka I, Chamie G, Dorsey G, Kamya MR, Charlebois E, Havlir DV, Cattamanchi A.  Read more
  30. Increased Morbidity in Early Childhood Among HIV-exposed Uninfected Children in Uganda is Associated with Breastfeeding Duration. J Trop Pediatr. 2014 Dec;60(6):434-41. doi: 10.1093/tropej/fmu045. Epub 2014 Aug 21. PMID: 25145704 Marquez C, Okiring J, Chamie G, Ruel TD, Achan J, Kakuru A, Kamya MR, Charlebois ED, Havlir DV, Dorsey G. Read more
  31. Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda. American Journal of Tropical Medicine and Hygiene 2014; 91:54-61, 2014. PMID: 24799371 Mbogo GW, Nankoberanyi S, Tukwasibwe S, Baliraine F, Nsobya SL, Conrad M, Arinaitwe E, Kamya MR, Tappero JW, Staedke S, Dorsey G, Greenhouse B, Rosenthal PJ. Read more
  32. Comparison of routine Health Management Information System versus enhanced inpatient malaria surveillance for estimating the burden of malaria among children admitted to four hospitals in Uganda. American Journal of Tropical Medicine and Hygiene 2014: Am J Trop Med Hyg. 2015 Jan 7;92(1):18-21. doi: 10.4269/ajtmh.14-0284. Epub 2014 Nov 24. Mpimbaza A, Miles M,  Sserwanga A,  Kigozi S, Kaaketo S, Kizito F, Rubahika D, Nasr S, Kapella BK, Yoon SS, Chang M, Yeka A, Staedke SG, Kamya MR, Dorsey G.Read more
  33. Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria. Malar J. 2014 Jan 28;13:32. doi: 10.1186/1475-2875-13-32. PMID: 24468007 Muhindo MK, Kakuru A, Jagannathan P, Talisuna A, Osilo E, Orukan F, Arinaitwe E, Tappero JW, Kaharuza F, Kamya MR, Dorsey G. Read more
  34. Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial. Clin Infect Dis. 2014 May;58(10):1404-12. doi: 10.1093/cid/ciu150. Epub 2014 Mar 12. PMID: 24621953 Nankabirwa JI, Wandera B, Amuge P, Kiwanuka N, Dorsey G, Rosenthal PJ, Brooker SJ, Staedke SG, Kamya MR. Read more
  35. Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda. Mal J. 2014;13:95. PMID: 24629020 Nankoberanyi S, Mbogo GW, LeClair NP, Conrad MD, Tumwebaze P, Tukwasibwe S, Kamya MR, Tappero J, Nsobya SL, Rosenthal PJ: Read more
  36. Reliability and validity of the center for epidemiologic studies-depression scale in screening for depression among HIV-infected and -uninfected pregnant women attending antenatal services in northern Uganda: a cross-sectional study. BMC Psychiatry. 2014 Nov 22;14(1):303. [Epub ahead of print] PMID: 25416286 Natamba BK, Achan J, Arbach A, Oyok TO, Ghosh S, Mehta S, Stoltzfus RJ, Griffiths JK, Young SL. Read more
  37. Reliability and validity of an individually focused food insecurity access scale for assessing inadequate access to food among pregnant Ugandan women of mixed HIV status. Public Health Nutr. 2014 Aug 29:1-11. [Epub ahead of print] PMID: 25171462 Natamba BK, Kilama H, Arbach A, Achan J, Griffiths JK, Young SL. Read more
  38. Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women. J Infect Dis. 2014 Dec 15;210(12):1938-45. doi: 10.1093/infdis/jiu346. Epub 2014 Jun 23. PMID: 24958908 Natureeba P, Ades V, Luwedde F, Mwesigwa J, Plenty A, Okong P, Charlebois ED, Clark TD, Nzarubara B, Havlir DV, Achan J, Kamya MR, Cohan D, Dorsey G. Read more
  39. Multilocus microsatellite genotyping array for investigation of genetic epidemiology of Pneumocystis jirovecii. J Clin Microbiol. 2014 May;52(5):1391-9. doi: 10.1128/JCM.02531-13. Epub 2014 Feb 12. PMID: 24523468 Parobek CM, Jiang LY, Patel JC, Alvarez-Martínez MJ, Miro JM, Worodria W, Andama A, Fong S, Huang L, Meshnick SR, Taylor SM, Juliano JJ. Read more
  40. Quantifying cross-border movements for guiding the strategic planning of malaria control and elimination. Malar J. 2014 May 3;13:169. doi: 10.1186/1475-2875-13-169. Pindolia D, Garcia AG, Huang Z, Fik T, Smith DL, Tatem AJ.Read more
  41. The practice of ‘doing’ evaluation: lessons learned from nine complex intervention trials in action. Implement Sci. 2014 Jun 17;9:75. doi: 10.1186/1748-5908-9-75. PMID: 24935096 Reynolds J, DiLiberto D, Mangham-Jefferies L, Ansah EK, Lal S, Mbakilwa H, Bruxvoort K, Webster J, Vestergaard LS, Yeung S, Leslie T, Hutchinson E, Reyburn H, Lalloo DG, Schellenberg D, Cundill B, Staedke SG, Wiseman V, Goodman C, Chandler CI. Read more
  42. Virologic and immunologic outcomes of HIV-infected Ugandan children randomized to lopinavir/ritonavir or nonnucleoside reverse transcriptase inhibitor therapy. J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):535-41. doi: 10.1097/QAI.0000000000000071. PMID: 24326597 Ruel TD, Kakuru A, Ikilezi G, Mwangwa F, Dorsey G, Rosenthal PJ, Charlebois E, Havlir D, Kamya M, Achan J. Read more
  43. Recasting the theory of mosquito-borne pathogen transmission dynamics and control. Trans R Soc Trop Med Hyg. 2014 Apr;108(4):185-97. PMID: 24591453 Smith DL, Perkins TA, Reiner RC Jr, Barker CM, Niu T, Chaves LF, Ellis AM, George DB, Le Menach A, Pulliam JR, Bisanzio D, Buckee C, Chiyaka C, Cummings DA, Garcia AJ, Gatton ML, Gething PW, Hartley DM, Johnston G, Klein EY, Michael E, Lloyd AL, Pigott DM, Reisen WK, Ruktanonchai N, Singh BK, Stoller J, Tatem AJ, Kitron U, Godfray HC, Cohen JM, Hay SI, Scott TW. Read more
  44. Estimation of malaria haplotype and genotype frequencies: a statistical approach to overcome the challenge associated with multiclonal infections. Malar J. 2014 Mar 17;13:102. doi: 10.1186/1475-2875-13-102. PMID: 2463667 Taylor AR, Flegg JA, Nsobya SL, Yeka A, Kamya MR, Rosenthal PJ, Dorsey G, Sibley CH, Guerin PJ, Holmes CC. Read more
  45. Absence of Putative Artemisinin Resistance Mutations Among Plasmodium falciparum in Sub-Saharan Africa: A Molecular Epidemiologic Study. J Infect Dis. 2014 Sep 1. pii: jiu467. [Epub ahead of print] PMID: 25180240 Taylor SM, Parobek CM, DeConti DK, Kayentao K, Coulibaly SO, Greenwood BM, Tagbor H, Williams J, Bojang K, Njie F, Desai M, Kariuki S, Gutman J, Mathanga DP, Mårtensson A, Ngasala B, Conrad MD, Rosenthal PJ, Tshefu AK, Moormann AM, Vulule JM, Doumbo OK, Ter Kuile FO, Meshnick SR, Bailey JA, Juliano JJ. Read more
  46. Procalcitonin predicts mortality in HIV-infected Ugandan adults with lower respiratory tract infections. Respirology. 2014 Apr;19(3):382-8. doi: 10.1111/resp.12237. Epub 2014 Jan 26. PMID: 24460728 Tokman S, Barnett CF, Jarlsberg LG, Taub PR, den Boon S, Davis JL, Cattamanchi A, Worodria W, Maisel A, Huang L; International HIV-Associated Opportunistic Pneumonias (IHOP) Study Group. Read more
  47. Differential prevalence of transporter polymorphisms and infection complexity in symptomatic and asymptomatic P. falciparum infections in Uganda. Journal of Infectious Diseases 2014; 210:154-7. PMID: 24446524 Tukwasibwe S, Mugenyi L, Mbogo GW, Nankoberanyi S, Maiteki-Sebuguzi C, Cundill B,  Joloba ML,  Nsobya SL, Dorsey G, Staedke SG, Rosenthal PJ. Read more
  48. Measuring changes in Plasmodium falciparum transmission: Precision, accuracy and costs of metrics. Advances in Parasitology 2014;84:151-208. PMID: 24480314 Tusting L, Bousema T, Smith DL, Drakeley C. Read more
  49. Long-lasting insecticide-treated bed net ownership and use among children under five years of age following a targeted distribution in central Uganda. Malar J. 2014 May 19;13:185. doi: 10.1186/1475-2875-13-185. Wanzira H, Yeka A, Kigozi R, Rubahika D, Nasr S, Sserwanga A, Kamya M, Filler S, Dorsey G, Steinhardt L. Read more
  50. Longitudinal outcomes in a cohort of Ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria.Clin Infect Dis. 2014 Aug 15;59(4):509-16. doi: 10.1093/cid/ciu353. Epub 2014 May 13. PMID: 24825870. Wanzira H, Kakuru A, Arinaitwe E, Bigira V, Muhindo MK, Conrad M, Rosenthal PJ, Kamya MR, Tappero JW, Dorsey G. Read more
  51. Contemporary gene flow between wild An. gambiae s.s. and An. arabiensis. Parasites and Vectors 2014;7:345. Weetman, D., Steen, K., Rippon, E.J., Mawejje, H.D., Donnelly, M.J. and Wilding, C.S (2014)
  52. Parellel evolution or purifying selection, not introgression, explains similarity in the pyrethroid detoxification linked GSTe4 of Anopheles gambiae and Anopheles arabiensis. Mol Genet Genomics. 2014 Sep 12. Wilding CS, Weetman D, Mawejje H, Donnelly MJ. Read more
  53. Efficacy and Safety of Fixed-Dose Artesunate-Amodiaquine vs. Artemether-Lumefantrine for Repeated Treatment of Uncomplicated Malaria in Ugandan Children. PLoS One. 2014 Dec 1;9(12):e113311. doi: 10.1371/journal.pone.0113311. eCollection 2014. PMID: 25436614 Yeka A, Lameyre V, Afizi K, Fredrick M, Lukwago R, Kamya MR, Talisuna AO. Read more
  54. Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV. J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):551-6. doi: 10.1097/QAI.0000000000000085. PMID: 24346636 Yoon C, Davis JL, Huang L, Muzoora C, Byakwaga H, Scibetta C, Bangsberg DR, Nahid P, Semitala FC, Hunt PW, Martin JN, Cattamanchi A. Read more
  55. I Have Remained Strong Because of That Food”: Acceptability and Use of Lipid-Based Nutrient Supplements Among Pregnant HIV-Infected Ugandan Women Receiving Combination Antiretroviral Therapy. AIDS Behav. 2014 Nov 22. [Epub ahead of print]PMID: 25416075 Young S, Natamba B, Luwedde F, Nyafwono D, Okia B, Osterbauer B, Natureeba P, Johnson L, Michel C, Zheng A, Robine M, Achan J, Charlebois E, Cohan D, Havlir D. ” Read more
  56. Household food insecurity, maternal nutritional status, and infant feeding practices among HIV-infected Ugandan women receiving combination antiretroviral therapy. Matern Child Health J. 2014 Nov;18(9):2044-53. doi: 10.1007/s10995-014-1450-y. PMID: 24585398 Young SL, Plenty AH, Luwedde FA, Natamba BK, Natureeba P, Achan J, Mwesigwa J, Ruel TD, Ades V, Osterbauer B, Clark TD, Dorsey G, Charlebois ED, Kamya M, Havlir DV, Cohan DL.  Read more
  1. Determining health-care facility catchment areas in Uganda using data on malaria-related visits. Bull World Health Organ. 2014 Mar 1;92(3):178-86. doi: 10.2471/BLT.13.125260. Epub 2014 Jan 10. PMID: 24700977 Zinszer K, Charland K, Kigozi R, Dorsey G, Kamya MR, Buckeridge DL. Read more
  2. WHO Option B+: Early Experience of Antiretroviral Therapy Sequencing after Cessation of Breastfeeding and Risk of Dermatologic Toxicity: JAIDS, 2013: PMID: 23924639 Cohan D, Mwesigwa J, Natureeba P, Luwedde FA, Ades V, Plenty A, Kakuru A, Achan J, Clark TD, Osterbauer B, Kamya MR, Havlir DV. Read more
  3. Hair and Plasma Data Show that Lopinavir, Ritonavir and Efavirenz All Transfer from Mother to Infant in Utero, but only Efavirenz Transfers via Breastfeeding. AIDS. PMID 24135775 Gandhi M, Mwesigwa J, Aweeka F, Plenty A, Charlebois E, Huang Y, Clark TD, Ades V, Natureeba P, Luwedde F, Achan J, Kamya MR, Havlir DV, Cohan D. Read more
  4. A Sticky Situation: The Unexpected Stability of Malaria Elimination. Philosophical Transactions of the Royal Society B: Biological Sciences. PMID 23798693. Chiyaka C, Tatem AJ, Cohen JM, Gething PW, Johnston G, Buckee CO, Laxminarayan R, Hay SI, Smith DL. Read more
  5. Neonatal Survival in HIV-exposed Infants Born to Women Receiving Combination Antiretroviral Therapy in Rural Uganda. J Trop Pediatr. 2013 Jun 13. PMID: 23764539 Ades V, Mwesigwa J, Natureeba P, Clark TD, Plenty A, Ruel T, Charlebois E, Achan J, Kamya MR, Havlir DV, Cohan D. Read more
  6. Fitness consequences of Plasmodium falciparum pfmdr1 polymorphisms inferred from ex vivo culture of Ugandan parasites. Antimicrob Agents Chemother. 2013 Jun 24. PMID: 23796921 Ochong E, Tumwebaze PK, Byaruhanga O, Greenhouse B, Rosenthal PJ.Read more
  7. The Effect of Indoor Residual Spraying on Malaria and Anemia in a High-Transmission Area of Northern Uganda. Am J Trop Med Hyg. 2013 Mar 4.PMID 23458956 Steinhardt LC, Yeka A, Nasr S, Wiegand RE, Rubahika D, Sserwanga A, Wanzira H, Lavoy G, Kamya M, Dorsey G, Filler S. Read more
  8. Improved employment, education, and economic outcomes in households of HIV-positive adults with high CD4 counts: evidence from a community-wide health campaign in Uganda. Thirumurthy H, Jain V, Chamie G, Geng E, Kabami J, Kwarisiima D, Clark TD, Petersen ML, Kamya M, Charlebois E, Havlir D, and the SEARCH Collaboration. AIDS. 2013 Feb 20;27(4):627-634. PMID: 23169332 Read more
  9. Assessment of Community Viral Load in a Rural East African Setting Using a Fingerprick-Based Blood Collection Method. PMID 23243180 Jain V, Liegler T, Kabami J, Chamie G, Clark TD, Black D, Geng E, Kwarisiima D, Wong J, Abdel-Mohsen M, Lizak P, Aweeka  F, Thirumurthy H, Petersen ML,  Charlebois ED, Kamya MR, Havlir DV, and the SEARCH Collaboration. Clin Infect Dis. 2013 Feb;56(4):598-605.Read more
  10. Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies. Am J Trop Med Hyg. 2013 Jan 28.  PMID: 23358639 Ikilezi G, Achan J, Kakuru A, Ruel T, Charlebois E, Clark TD, Rosenthal PJ, Havlir DV, Kamya MR, Dorsey G. Read more
  11. Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children. PLoS One. 2013;8(1):e53772.PMID 23349741 Yeka A, Tibenderana J, Achan J, D’Alessandro U, Talisuna AO. Read more
  12. he Use of Census Migration Data to Approximate Human Movement Patterns across Temporal Scales. PLoS One 2013; 8:e52971. Wesolowski ,Buckee CO,Pindolia DK,Eagle N,Smith DL,Garcia AJ,Tatem AJ Read more
  13. A systematic review of mathematical models of mosquito-borne pathogen transmission: 1970-2010. Journal of the Royal Society, Interface 2013;10(81):20120921.PMID 23407571 Reiner RC, Perkins TA, Barker CM, Niu T, Chaves LF, Ellis AM, George DB, Le Menach A, Pulliam J, Bisanzio D, Buckee C, Chiyaka C, Cummings DAT, Garcia A, Gatton M, Gething PW, Hartley DM, Hartley DM, Johnston G, Klein EY, Michael E, Lindsay SW, Lloyd AL, Pigott D, Reisen WK, Ruktanonchai N, Singh B, Tatem AJ, Kitron U, Hay SI, Scott TW, Smith DL. Read more
  14. Infectious Disease. The stability of malaria elimination. Science 2013;339(6122):909-10.PMID 23430640 Chiyaka C, Tatem AJ, Cohen JM, Gething PW, Johnston G, Laxminarayan R, Hay SI, Smith DL. Read more
  1. Malaria′s missing number: calculating the human component of R0 by a within-host mechanistic model of Plasmodium falciparum infection and transmission. PLoS Comput Biol 2013;9(4):e1003025.PMID 23637586 Johnston G, Smith DL, and Fidock D. Read more
  2. Factors associated with malaria parasitemia, malnutrition, and anemia among HIV-exposed and unexposed Ugandan infants. Malar J. 2012 Dec 27;11(1):432. PMID: 23270614 Osterbauer B, Kapisi J, Bigira V, Mwangwa F, Kinara S, Kamya MR, Dorsey G. Read more
  3. Associations between antibodies to a panel of Plasmodium falciparum specific antigens and response to sub-optimal antimalarial therapy in Kampala, Uganda. PLoS One. 2012;7(12):e52571. doi: 10.1371/journal.pone.0052571. Epub 2012 Dec 19. PMID: 23285095 Keh CE, Jha AR, Nzarubara B, Lanar DE, Dutta S, Theisen M, Rosenthal PJ, Dorsey G, Nixon DF, Greenhouse B. Read more
  4. Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children. N Engl J Med. 2012 Nov 29;367(22):2110-8. PMID: 23190222 Achan J, Kakuru A, Ikilezi G, Ruel T, Clark TD, Nsanzabana C, Charlebois ED, Aweeka F, Dorsey G, Rosenthal PJ, Havlir DV, Kamya MR. Read more
  5. Insecticide resistance monitoring of field-collected Anopheles gambiae s.l. populations from Jinja, eastern Uganda, identifies high levels of pyrethroid resistance. Med Vet Entomol. 2012 Oct 10. doi: 10.1111/j.1365-2915.2012.01055.x. PMID: 23046446 Mawejje H, Wilding CS, Rippon EJ, Hughes A, Weetman D, Donnelly MJ. Read more
  6. Improved clinical and laboratory skills after team-based, malaria case management training of health care professionals in Uganda. Malar J. 2012 Feb 13;11:44: PMID 22330281 Namagembe A, Ssekabira U, Weaver MR, Blum N, Burnett S, Dorsey G, Sebuyira LM, Ojaku A, Schneider G, Willis K, Yeka A. Read more
  7. Evidence for both innate and acquired mechanisms of protection from Plasmodium falciparum in children with sickle cell trait. Blood. 2012 Apr 19;119(16):3808-14. Epub 2012 Feb 10. PMID: 22327223 Gong L, Maiteki-Sebuguzi C, Rosenthal PJ, Hubbard AE, Drakeley CJ, Dorsey G, Greenhouse B. Read more
  8. Maternal Nutritional Status Predicts Adverse Birth Outcomes among HIV-Infected Rural Ugandan Women Receiving Combination Antiretroviral Therapy. PLoS ONE 2012, 7:e41934. PMID: 22879899 Young S, Murray K, Mwesigwa J, Natureeba P, Osterbauer B, Achan J, Arinaitwe E, Clark T, Ades V, Plenty A, Charlebois E, Ruel T, Kamya M, Havlir D, Cohan D. Read more
  9. The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa. Future Virol. 2012;7(7):699-708. PMID: 23293660 Kamya MR, Byakika-Kibwika P, Gasasira AF, Havlir D, Rosenthal PJ, Dorsey G, Achan J. Read more
  10. Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda. PMID 22916256 PLoS One 2012;7(8):e43400. Chamie G, Kwarisiima D, Clark TD, Kabami J, Jain V, Geng E, Petersen ML, Thirumurthy H, Kamya MR, Havlir DV, Charlebois ED, and the SEARCH Collaboration. Read more
  11. Challenges to control on the long road to elimination. II. The path forward. Acta Tropica 2012;121(3):196-201.PMID 21756863 Talisuna A, Adibaku S, Dorsey G, Kamya MR, Rosenthal PJ. Malaria in Uganda: Read more
  12. Malaria in Uganda: Challenges to control on the long road to elimination I. Epidemiology and current control efforts. Acta Tropica 2012; 121(3):184-95.PMID 21420377 Read more
  13.  Ross, Macdonald ans a Theory for the Dynamics and Control of Mosquito-Transmitted Pathogens. PLoS Pathogens 2012; 8(4): e1002588.PMID 22496640 Smith DL, Battle KE, Hay SI, Barker CM, Scott TW, & McKenzie, FE. Read more
  14. Health facility based malaria surveillance: the effects of age, geography, and diagnostics on test positivity rates. Malaria Journal 2012;11(1):229.PMID 22770511 Francis D, Gasasira A, Kigozi R, Kigozi SP, Nasr S, Kamya MR, Dorsey G. Read more
  15. Human movement data for malaria control and elimination strategic planning, Malaria Journal 2012;11:205. Pindolia DK, Garcia AJ, Wesolowski A, Smith DL, Buckee CO, Noor AM, Snow RW, Tatem AJ. Read more
  16. Indoor Residual Spraying of Insecticide and Malaria Morbidity in a High Transmission Insensity Area of Uganda. PLoS One 2012;7(8):e42857.PMID 22880123 Kigozi R, Baxi SM, Gasasira A,Sserwanga A, Kakeeto S, Sussann N, Rubahika D, Gunawardena D, Kamya MR, Filler S, Dorsey G. Read more
  17. Mapping regional movements of human malaria parasite vectors. Science 2012;338(6104):267-70.PMID: 23478045 Wesolowski A, Eagle N, Smith DL, Tatem AJ, Noor AM, Snow RW, Buckee CO. Read more
  1. Associations between multiple antibodies to Plasmodium falciparum and response to sub-optimal antimalarial therapy in Kampala, Uganda.  PLoS One 2012;7(12):e52571.PMID: 28923866 Keh CE, Jha AR, Nzarubara B, Lanar DE, Dutta S, Theisen M, Rosenthal PJ, Dorsey G, Nixon DF, Greenhouse B. Read more
  2. In vitro activity of antiretroviral drugs against Plasmodium falciparum. Nsanzabana C, Rosenthal PJ. Antimicrob Agents Chemother. 2011 Nov;55(11):5073-7. PMID: 21876053 Tatem AJ, Gething PW, Smith DL, Hay SI. Urbanization and the global malaria recession. Malaria Journal 2013;12:133. Read more
  3. The seroprevalence of Helicobacter pylori and its relationship to malaria in Ugandan children. Trans R Soc Trop Med Hyg. 2012 Jan;106(1):35-42. Epub 2011 Oct 20. PMID: 2201860 Gupta V, Perez-Perez GI, Dorsey G, Rosenthal PJ, Blaser MJ. Read more
  4. Sex differences in HIV RNA level and CD4 cell percentage during childhood.Clin Infect Dis. 2011 Sep;53(6):592-9. doi: 10.1093/cid/cir484. PMID 21840929 Ruel TD, Zanoni BC, Ssewanyana I, Cao H, Havlir DV, Kamya M, Achan J, Charlebois ED, Feeney ME. Read more
  5. Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. J Infect Dis. 2011 Jul 1;204(1):19-26. PMID: 21628654 Greenhouse B, Ho B, Hubbard A, Njama-Meya D, Narum DL, Lanar DE, Dutta S, Rosenthal PJ, Dorsey G, John CC. Read more
  6. Evaluation of a comprehensive refresher training program in malaria microscopy covering four districts of Uganda. Am J Trop Med Hyg. 2011 May;84(5):820-4.PMID 21540396 Kiggundu M, Nsobya SL, Kamya MR, Filler S, Nasr S, Dorsey G, Yeka A. Read more
  7. Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda. Antimicrob Agents Chemother. 2011 Feb;55(2):615-22. PMID 21078941 Baliraine FN, Nsobya SL, Achan J, Tibenderana JK, Talisuna AO, Greenhouse B, Rosenthal PJ. Read more
  8. Improved malaria case management through the implementation of a health facility-based sentinel site surveillance system in Uganda. PLoS One. 2011 Jan 19;6(1):e16316. doi: 10.1371/journal.pone.0016316.PMIN 21283815 Sserwanga A, Harris JC, Kigozi R, Menon M, Bukirwa H, Gasasira A, Kakeeto S, Kizito F, Quinto E, Rubahika D, Nasr S, Filler S, Kamya MR, Dorsey G. Read more
  9. Short-Term Risk of HIV Disease Progression and Death in Ugandan Children Not Eligible for Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes, J Acquir Immune Defic Syndr. 2010 Nov 1;55(3):330-5. PMCID: PMC3025136 Charlebois ED, Ruel TD, Gasasira AF, Achan J, Kateera F, Akello C, Cao H, Dorsey G, Rosenthal PJ, Ssewanyana I, Kamya MR, Havlir DV.  Read more
  10. Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children. J Acquir Immune Defic Syndr 2010; 56:44-50. NIHMS253000. PMID: 25166019 Ruel TD, Kamya MR, Li P, Pasutti W, Charlebois ED, Liegler T, Dorsey G, Rosenthal PJ, Havlir DV,  Wong JK, Achan J. Read more
  11. Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children. PLoS One. 2010 Jul 30;5(7):e11759.PMID 20689585 Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Greenhouse B, Staedke SG, Kamya MR, Dorsey G, Rosenthal PJ. Read more
  12. Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance. Malaria Journal. 2010 Jun 23;9(1):177. PMID:20573194: PMCID: PMC2903607 Gasasira AF, Kamya MR, Ochong EO, Vora N, Achan J, Charlebois E, Ruel T, Kateera F, Meya DN, Havlir D, Rosenthal PJ, Dorsey G.  Read more
  13. HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children.  AIDS. 2010 May 15;24(8):1163-70. PMCID: PMC2880483 Boivin MJ, Ruel TD, Boal HE, Bangirana P, Cao H, Eller LA, Charlebois E, Havlir DV, Kamya MR, Achan J, Akello C, Wong JK.  Read more
  14. Gel versus capillary electrophoresis genotyping for categorizing treatment outcomes in two anti-malarial trials in Uganda. Malar J. 2010 Jan 15;9:19. PMID: 20074380 Gupta V, Dorsey G, Hubbard AE, Rosenthal PJ, Greenhouse B. Read more
  15. Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda. Antimicrob Agents Chemother. 2010 Jan;54(1):52-9. Mwesigwa J, Parikh S, McGee B, German P, Drysdale T, Kalyango JN, Clark TD, Dorsey G, Lindegardh N, Annerberg A, Rosenthal PJ, Kamya MR, Aweeka F. Read more
  16. Treating uncomplicated malaria in children: comparing artemisinin-based combination therapies. Curr Opin Pediatr. 2010 Dec;22(6):798-803. Yeka A, Harris JC. Read more
  17. Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria. AIDS. 2010 Jul 31;24(12):1945-52. Bebell L. M, Pilcher C D, Dorsey G, Havlir D, Kamya M R, Busch M P, Dunn Williams J, Nugent C T, Bentsen C, Rosenthal P J, Charlebois E D.Read more
  18. Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda. Malaria Journal 2009:8:254:14 Nov 2009. PMCID: PMC2666158. Newman PM, Wanzira H, Tumwine G, Arinaitwe E, Waldman S, Achan J, Havlir D, Rosenthal PJ, Dorsey G, Clark TD, Cohan D. Read more
  19. Use of the slide positivity rate to estimate changes in malaria incidence in a cohort of Ugandan children. Malar J. 2009 Sep 15;8:213. PMID: 19754955 Jensen TP, Bukirwa H, Njama-Meya D, Francis D, Kamya MR, Rosenthal PJ, Dorsey G. Read more
  20. Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility. PLoS One. 2009 Sep 30;4(9):e7246. Johnson MK, Clark TD, Njama-Meya D, Rosenthal PJ, Parikh S. Read more
  21. Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy?. Lancet Infect Dis. 2009 Jul;9(7):448-52.PMID 19555904 Yeka A, Achan J, D’Alessandro U, Talisuna AO. Read more
  22. Dynamics of T-cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children. Clinical Immunology,  Volume 131, Issue 3, June 2009, Pages 410-414. NIHMSID # 268410: PMID: 19303366 Ruel T, Ssewanyana I, Achan J, Gasasira A, Kamya MR, Kekitiinwa A, Wong J, Cao H, Havlir D, Charlebois E. Read more
  23. Decreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistance. J Infect Dis. 2009 Mar 1;199(5):758-6 :PMID: 19199542 Greenhouse B, Slater M, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Clark TD, Staedke SG, Kamya MR, Hubbard A, Rosenthal PJ, Dorsey G. Read more
  24. The distribution and immune profile of T cells subsets in HIV infected children from Uganda. (AIDS Research and Human Retroviruses, 2009 Jan; 25(1):65-71). PMCID: PMC2858297. Ssewanyana I, Baker CAR, Ruel T, Bousheri S, Kamya M, Dorsey G, Rosenthal PJ, Charlebois E, Havlir D, Cao H. Read more
  25. Prophylaxis and treatment of Malaria in HIV infected populations. Future HIV Ther, September 2008, Vol. 2, No. 5, Pages 453-464 Achan J, Gasasira AF, Aweeka F, Havlir D, Rosenthal PJ, Kamya, MR. Read more
  26. Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda. J Infect Dis. 2008 Aug 1;198(3):393-400. Clark TD, Greenhouse B, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Staedke SG, Seto E, Kamya MR, Rosenthal PJ, Dorsey G. Read more
  27. Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda. Malar J. 2008 Jun 11;7:107. Staedke SG, Jagannathan P, Yeka A, Bukirwa H, Banek K, Maiteki-Sebuguzi C, Clark TD, Nzarubara B, Njama-Meya D, Mpimbaza A, Rosenthal PJ, Kamya MR, Wabwire-Mangen F, Dorsey G, Talisuna AO. Read more
  28. Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. Malar J. 2008 Jun 11;7:106 Maiteki-Sebuguzi C, Jagannathan P, Yau VM, Clark TD, Njama-Meya D, Nzarubara B, Talisuna AO, Kamya MR, Rosenthal PJ, Dorsey G, Staedke SG. Read more
  29. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PLoS One. 2008 Jun 11;3(6):e2390. Yeka A, Dorsey G, Kamya MR, Talisuna A, Lugemwa M, Rwakimari JB, Staedke SG, Rosenthal PJ, Wabwire-Mangen F, Bukirwa H. Read more
  30. HIV RNA suppression among HIV-infected Ugandan Children with Measles.  JAIDS 2008:48(2), (1 June):225-227). NIHMSID # 268409. Ruel T, Achan J, Gasasira AF, Charlebois ED, Mebrahtu T, Rosenthal PJ, Dorsey G, Kamya MR, Kekitiinwa A, Wong J, Havlir DV. Read more
  31. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. CID 2008:46 (1 April:992-3). PMCID: 18444813 Gasasira AF, Kamya MR, Achan J, Mebrahtu T, Kalyango, J, Ruel T, Charlebois E, Staedke SG, Kekitiinwa A, Rosenthal P, Havlir D, and Dorsey G. Read more
  32. Rapid diagnostic tests for malaria at sites of varied transmission intensity in Uganda; J Infect Dis. 2008 Feb 15;197(4):510-8. PMID 18240951 Hopkins H, Bebell L, Kambale W, Dokomajilar C, Rosenthal PJ, Dorsey G.  Read more
Avantage
Headquarters
Visualize quality intellectual capital without superior collaboration and idea sharing installed base portals.
619 270 8578
info@avantage.com
avantage.com
Our locations
Where to find us?
https://www.idrc-uganda.org/wp-content/uploads/2020/04/img-footer-map.png
San Diego: 619 270 8578
Ontario: 613 285 5534
London: 020 7946 0020
Get in touch
Avantage Social links
Taking seamless key performance indicators offline to maximise the long tail.
Avantage
Headquarters
Visualize quality intellectual capital without superior collaboration and idea sharing installed base portals.
619 270 8578
info@avantage.com
avantage.com
Our locations
Where to find us?
https://www.idrc-uganda.org/wp-content/uploads/2020/04/img-footer-map.png
San Diego: 619 270 8578
Ontario: 613 285 5534
London: 020 7946 0020
Get in touch
Avantage Social links
Taking seamless key performance indicators offline to maximise the long tail.

Developed with ❤ by Invictus Tech.

Developed with ❤ by Invictus Tech.